<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9440295</article-id><article-id pub-id-type="pii">S2589-0042(22)01219-6</article-id><article-id pub-id-type="doi">10.1016/j.isci.2022.104947</article-id><article-id pub-id-type="publisher-id">104947</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>3D bioprinting of nanoparticle-laden hydrogel scaffolds with enhanced antibacterial and imaging properties</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Theus</surname><given-names>Andrea S.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Ning</surname><given-names>Liqun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Kabboul</surname><given-names>Gabriella</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Hwang</surname><given-names>Boeun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Tomov</surname><given-names>Martin L.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>LaRock</surname><given-names>Christopher N.</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Bauser-Heaton</surname><given-names>Holly</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="aff6" ref-type="aff">6</xref><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author" id="au8"><name><surname>Mahmoudi</surname><given-names>Morteza</given-names></name><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author" id="au9"><name><surname>Serpooshan</surname><given-names>Vahid</given-names></name><email>vahid.serpooshan@bme.gatech.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="aff6" ref-type="aff">6</xref><xref rid="fn1" ref-type="fn">9</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA 30322, USA</aff><aff id="aff2"><label>2</label>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA</aff><aff id="aff3"><label>3</label>Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA 30322, USA</aff><aff id="aff4"><label>4</label>Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA</aff><aff id="aff5"><label>5</label>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA</aff><aff id="aff6"><label>6</label>Children&#x02019;s Healthcare of Atlanta, Atlanta, GA 30322, USA</aff><aff id="aff7"><label>7</label>Sibley Heart Center at Children&#x02019;s Healthcare of Atlanta, Atlanta, GA 30342, USA</aff><aff id="aff8"><label>8</label>Precision Health Program, Michigan State University, East Lansing, MI 48842, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>vahid.serpooshan@bme.gatech.edu</email></corresp><fn id="fn1"><label>9</label><p id="ntpara0010">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>15</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>8</month><year>2022</year></pub-date><volume>25</volume><issue>9</issue><elocation-id>104947</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2022</year></date><date date-type="rev-recd"><day>13</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 The Author(s)</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Biomaterial-associated microbial contaminations in biologically conducive three-dimensional (3D) tissue-engineered constructs have significantly limited the clinical applications of scaffold systems. To prevent such infections, antimicrobial biomaterials are rapidly evolving. Yet, the use of such materials in bioprinting-based approaches of scaffold fabrication has not been examined. This study introduces a new generation of bacteriostatic gelatin methacryloyl (GelMA)-based bioinks, incorporated with varying doses of antibacterial superparamagnetic iron oxide nanoparticles (SPIONs). The SPION-laden GelMA scaffolds showed significant resistance against the <italic>Staphylococcus aureus</italic> growth, while providing a contrast in magnetic resonance imaging. We simulated the bacterial contamination of cellular 3D GelMA scaffolds <italic>in&#x000a0;vitro</italic> and demonstrated the significant effect of functionalized scaffolds in inhibiting bacterial growth, while maintaining cell viability and growth. Together, these results present a new promising class of functionalized bioinks to 3D bioprint tissue-engineered scaffold with markedly enhanced properties for the use in a variety of <italic>in&#x000a0;vitro</italic> and clinical applications.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Functionalized bioinks with bacteriostatic properties are developed and thoroughly characterized</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">The 200&#x000a0;&#x003bc;g/mL group yielded an optimal balance of printed scaffold properties</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Incorporating nanoparticle also enabled noninvasive imaging of the bioprinted scaffold</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Biomaterials; Nanoparticles; Tissue engineering</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Biomaterials</kwd><kwd>Nanoparticles</kwd><kwd>Tissue engineering</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: September 16, 2022</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0045">Additive biomanufacturing techniques, such as three-dimensional (3D) bioprinting, have emerged in the tissue engineering field, offering many advantages in developing tissue models for use in regenerative medicine applications (<xref rid="bib11" ref-type="bibr">Chan et&#x000a0;al., 2020</xref>; <xref rid="bib12" ref-type="bibr">Chung et&#x000a0;al., 2020</xref>; <xref rid="bib61" ref-type="bibr">Serpooshan and Guvendiren, 2020</xref>; <xref rid="bib71" ref-type="bibr">Tomov et&#x000a0;al., 2019a</xref>). By controlling the size, shape, and architecture of manufactured constructs, 3D bioprinting allows for the assembly of tissue analogs with highly biomimetic structural and functional properties. The bioink, which is typically a blend of biomaterials, biological and chemical components, and often times living cells, is a critical component of tissue bioprinting and structure fidelity (<xref rid="bib23" ref-type="bibr">H&#x000f6;lzl et&#x000a0;al., 2016</xref>; <xref rid="bib47" ref-type="bibr">Ning et&#x000a0;al., 2020</xref>; <xref rid="bib73" ref-type="bibr">Tomov et&#x000a0;al., 2020</xref>). Commonly, materials such as biodegradable hydrogels have been used as the base of bioinks as they inherently mimic the native tissue microenvironments and properties (<xref rid="bib31" ref-type="bibr">Lee and Kim, 2018</xref>). Specifically, the use of gelatin methacryloyl (GelMA) as a bioink has recently gained increasing attention in the field due its facile tunability, adequate biocompatibility and bioactivity, and the ability to covalently crosslink via various light activated photoinitiators (<xref rid="bib80" ref-type="bibr">Yue et&#x000a0;al., 2015</xref>). GelMA hydrogel bioinks can be readily incorporated with factors, such as nanoparticles (NPs), to create composite functionalized bioinks for diverse tissue engineering applications (<xref rid="bib73" ref-type="bibr">Tomov et&#x000a0;al., 2020</xref>). This allows for the formation of a colloidal matrix that can further improve the structural stability and print fidelity along with increasing the desired biological properties of the hydrogel composite matrix (<xref rid="bib8" ref-type="bibr">Bhattacharyya et&#x000a0;al., 2021</xref>).</p><p id="p0050">Clinical-scale tissue bioprinting and <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic> applications of 3D printed scaffolds have been challenged by the difficulty to maintain these constructs infection free, particularly pre-operation (<xref rid="bib9" ref-type="bibr">Busscher et&#x000a0;al., 2012</xref>; <xref rid="bib28" ref-type="bibr">Kuijer et&#x000a0;al., 2007</xref>; <xref rid="bib81" ref-type="bibr">Zimmerli and Trampuz, 2013</xref>). This is mainly due to their inherent nature as highly favorable culture systems. Biomaterial-related bacterial infection is a common cause of graft failure of implanted devices <italic>in&#x000a0;vivo</italic> (<xref rid="bib81" ref-type="bibr">Zimmerli and Trampuz, 2013</xref>). <italic>Staphylococcus aureus</italic> (<italic>S.&#x000a0;aureus</italic>) is a member of the normal human skin microbiota and one of the most common causes of hospital-acquired infection and wound infection following surgery (<xref rid="bib51" ref-type="bibr">Offerhaus et&#x000a0;al., 2019</xref>). Increasing rates of antibiotic resistance make treatment of these infections difficult and have led to an emphasis on prophylaxis, infection control, and antisepsis (<xref rid="bib25" ref-type="bibr">Johnson and Garcia, 2015</xref>). Commonly, organic antimicrobial compounds have been utilized to tackle this issue (<xref rid="bib18" ref-type="bibr">Greenhalgh et&#x000a0;al., 2019</xref>). Yet, such methods face major challenges due to their toxicity and/or antibiotic resistance rate, whereas the interest in inorganic disinfectants such as metal oxides is increasing (<xref rid="bib1" ref-type="bibr">Abat et&#x000a0;al., 2018</xref>; <xref rid="bib20" ref-type="bibr">Hajipour et&#x000a0;al., 2012</xref>). A variety of GelMA-based hydrogel systems with enhanced antibacterial properties have been created, including the polycaprolactone-GelMA-cephalexin electrospun nanofibrous scaffolds for wound healing applications (<xref rid="bib6" ref-type="bibr">Bakhsheshi-Rad et&#x000a0;al., 2019</xref>), a GelMA-based hydrogel drug delivery system used for local delivery of antibiotic cefazolin (<xref rid="bib76" ref-type="bibr">Vigata et&#x000a0;al., 2021</xref>), and a 3D printed GelMA scaffold laden with antibacterial tetrapodal zinc oxide microparticles (<xref rid="bib67" ref-type="bibr">Siebert et&#x000a0;al., 2021</xref>). While significant progress has been made, a GelMA-based bioink, with well-characterized antibacterial, printability, imaging, and cell support characteristics, has not been established for 3D bioprinting applications.</p><p id="p0055">Recent advances in the use of nanobiomaterials for tissue engineering and cell therapy applications have shown great promise in eliciting desired cellular and tissue response (<xref rid="bib29" ref-type="bibr">Kumar and Abrahamse, 2020</xref>; <xref rid="bib62" ref-type="bibr">Serpooshan et&#x000a0;al., 2018</xref>; <xref rid="bib75" ref-type="bibr">Uskokovic, 2017</xref>). The versatile and unique properties of NPs have rapidly established their use in a wide range of clinical applications such as drug delivery, targeted therapy, thermal ablation, medical imaging, and more relevantly 3D printing (<xref rid="bib22" ref-type="bibr">Hasan et&#x000a0;al., 2018</xref>). More recent studies have uncovered key advantages of NPs over traditional antibiotics (e.g., penicillin, methicillin, erythromycin, and vancomycin) to combat microbial activity (<xref rid="bib26" ref-type="bibr">Khezerlou et&#x000a0;al., 2018</xref>; <xref rid="bib77" ref-type="bibr">Wang et&#x000a0;al., 2017</xref>). In particular, superparamagnetic iron oxide NPs (SPIONs) have attracted growing attention as contrast agents for MRI and as robust antibacterial agents (<xref rid="bib3" ref-type="bibr">Ai et&#x000a0;al., 2016</xref>; <xref rid="bib21" ref-type="bibr">Hajipour et&#x000a0;al., 2021</xref>; <xref rid="bib45" ref-type="bibr">Nehra et&#x000a0;al., 2018</xref>). The antibacterial properties of SPIONs are tunable by controlling their size, which is of high importance due to the differences in cell envelope between Gram-positive and Gram-negative bacterial species (<xref rid="bib74" ref-type="bibr">Tran et&#x000a0;al., 2010</xref>). In this study, we incorporated varying doses of SPIONs in 3D bioprinting of tissue engineering scaffolds and examined the NPs effect on biofilm formation and MRI visibility of constructs (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>). Bioprinted GelMA constructs, functionalized with the antibacterial NPs, provided mechanical stability for the <italic>in&#x000a0;vitro</italic> 3D culture, and supported endothelial cell viability and growth, while exhibiting significant bacteriostatic effect.</p></sec><sec id="sec2"><title>Results and discussion</title><p id="p0060">To date, the use of tissue-engineered scaffolds and medical devices is hindered by the biomaterial-associated infection as well as the impaired visibility of the 3D scaffolds in both <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic> applications. We recently demonstrated that incorporation of SPIONs into a collagen type I-based cardiac patch could offer MRI-visibility, while impeding the growth of <italic>Salmonella</italic> bacteria in the patch (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>). This work evaluated, for the first time, the use of these FDA-approved NPs in developing a novel generation of functionalized bioinks for 3D bioprinting of anti-infection and MRI-visible tissue constructs. As the fields of additive biomanufacturing and tissue bioprinting advance toward <italic>in situ</italic> fabrication of biological products into the patient body and other translational applications (<xref rid="bib2" ref-type="bibr">Agarwal et&#x000a0;al., 2020</xref>; <xref rid="bib4" ref-type="bibr">Albanna et&#x000a0;al., 2019</xref>; <xref rid="bib68" ref-type="bibr">Singh et&#x000a0;al., 2020</xref>), the need for anti-infection bioinks that also allow for noninvasive, longitudinal monitoring of engineered scaffolds is paramount. In this study, GelMA-based bioinks were supplemented with varying concentrations of SPIONs and their cytocompatibility, resistance to bacterial growth, and MR imaging properties were assessed <italic>in&#x000a0;vitro</italic> (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>). The specific range of SPION concentration (100&#x02013;500&#x000a0;&#x003bc;g/mL) was selected based upon our prior experiences working with these engineered NP systems (<xref rid="bib37" ref-type="bibr">Mahmoudi et&#x000a0;al., 2011a</xref>, <xref rid="bib35" ref-type="bibr">2012a</xref>, <xref rid="bib36" ref-type="bibr">2012b</xref>; <xref rid="bib64" ref-type="bibr">Sharifi et&#x000a0;al., 2012</xref>). Doses lower than 100&#x000a0;&#x003bc;g/mL would not yield sufficient antibacterial or imaging effects (<xref rid="bib37" ref-type="bibr">Mahmoudi et&#x000a0;al., 2011a</xref>). Concentrations higher than 500&#x000a0;&#x003bc;g/mL often result in particle aggregation, which could be detrimental for the extrusion bioprinting processes; there could also be the risk of cytotoxicity at higher SPION doses (<xref rid="bib35" ref-type="bibr">Mahmoudi et&#x000a0;al., 2012a</xref>, <xref rid="bib36" ref-type="bibr">2012b</xref>; <xref rid="bib64" ref-type="bibr">Sharifi et&#x000a0;al., 2012</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Schematic overview of the experimental design for the fabrication and <italic>in&#x000a0;vitro</italic> analysis of bacteriostatic 3D scaffold systems</p><p>(A&#x02013;E) A CAD model of the 3D geometry of interest was designed (A)&#x000a0;and bioprinted (B)&#x000a0;using various GelMA bioinks containing 0 (control), 100, 200, and 500&#x000a0;&#x003bc;g/mL of superparamagnetic iron oxide nanoparticles (SPIONs) to create the 3D scaffolds (C). Bioprinted scaffolds were assessed for printing fidelity, mechanical, and MR imaging properties (D), and seeded with human cells (fluorescently tagged endothelial cells) and/or bacteria (luminescent <italic>Staphylococcus aureus</italic>) (E)&#x000a0;for the <italic>in&#x000a0;vitro</italic> 3D culture assays.</p><p>(F) The time line for the <italic>in&#x000a0;vitro</italic> culture assays. Constructs were cultured either for 5&#x000a0;days (bacteria and human cell coculture) or 14&#x000a0;days (endothelial cell culture) and examined via AlamarBlue and imaging techniques. In panel (F), gray color represents the experimental steps for both bacteria and cell culture assays; brown: steps for the bacteria assays; and green: steps for the endothelial cell culture</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0065">Printing fidelity measurements of a two-layer cross hatch design, at 1.5X and 4&#x000d7; magnifications, demonstrated a relative reproducibility for each bioink composition including the control GelMA group (10% w/v), and GelMA supplemented with 100, 200, and 500&#x000a0;&#x003bc;g/mL of SPIONs (<xref rid="fig2" ref-type="fig">Figures&#x000a0;2</xref>A and 2B, <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S1</xref>). The geometric parameters of each print were compared against those in the CAD model to obtain the strand diameter <inline-formula><mml:math id="M1" altimg="si1.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, strand uniformity <inline-formula><mml:math id="M2" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, strand angle <inline-formula><mml:math id="M3" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and inter-strand area <inline-formula><mml:math id="M4" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> ratios (Equations <xref rid="fd5" ref-type="disp-formula">(Equation&#x000a0;5)</xref>, <xref rid="fd6" ref-type="disp-formula">(Equation&#x000a0;6)</xref>, <xref rid="fd7" ref-type="disp-formula">(Equation&#x000a0;7)</xref>, <xref rid="fd8" ref-type="disp-formula">(Equation&#x000a0;8)</xref>, <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C). The strand diameter ratio (<inline-formula><mml:math id="M5" altimg="si1.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) varied between 1.13 and 1.83 for the four study groups. The 200 and 500&#x000a0;&#x003bc;g/mL SPION groups showed significantly higher <inline-formula><mml:math id="M6" altimg="si1.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> ratios (p&#x000a0;&#x0003c;&#x000a0;0.0001), compared to the control and 100&#x000a0;&#x003bc;g/mL SPION groups, suggesting reduced printing fidelity once the NP concentration exceeds a certain (optimal) threshold. This is while strand uniformity (<inline-formula><mml:math id="M7" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) ranged from 0.97 to 0.99, and inter-strand angle (<inline-formula><mml:math id="M8" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) ratios ranged from 0.96 to 1.01 for all groups, with no significant differences (p&#x000a0;&#x0003e;&#x000a0;0.05). The approximation of <inline-formula><mml:math id="M9" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M10" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> ratios to 1 signifies the appropriate 2D and 3D printing accuracy in reference to the CAD model. The inter-strand area (<inline-formula><mml:math id="M11" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) ranged at higher values, however, from 1.59 to 1.64, while there were still no significant differences (p&#x000a0;&#x0003e;&#x000a0;0.05) across the study groups. Overall, the no SPIONs and 100&#x000a0;&#x003bc;g/mL SPIONs bioinks exhibited the optimal printing fidelity characteristics. Qualitative evaluation of SPION-laden bioinks suggested no significantly adverse effect of the incorporated NPs in the photocrosslinking process of the GelMA hydrogel, as also reported by other groups (<xref rid="bib30" ref-type="bibr">Kurian et&#x000a0;al., 2022</xref>). Potential effect of SPIONs incorporation on the crosslinking of GelMA bioinks can be precisely examined, in the future works, using NMR analysis (<xref rid="bib47" ref-type="bibr">Ning et&#x000a0;al., 2020</xref>).<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Printing fidelity assessment of functionalized bioinks</p><p>(A) Representative optical (bright-field) images acquired for fidelity measurements for each GelMA bioink group: 0 (control), 100, 200, and 500&#x000a0;&#x003bc;g/mL SPIONs, at 1.5X (top) and 4&#x000d7; (bottom) magnifications. Scale bars in top and bottom rows represent 2 mm and 1 mm, respectively.</p><p>(B) Definition of the four geometric ratios quantified from microscopy images in (A)&#x000a0;to assess fidelity of a 2-layer printed GelMA structure. These parameters include the strand diameter <inline-formula><mml:math id="M12" altimg="si1.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, strand uniformity <inline-formula><mml:math id="M13" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, strand angle <inline-formula><mml:math id="M14" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and inter-strand area <inline-formula><mml:math id="M15" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> ratios (Equations <xref rid="fd5" ref-type="disp-formula">(Equation&#x000a0;5)</xref>, <xref rid="fd6" ref-type="disp-formula">(Equation&#x000a0;6)</xref>, <xref rid="fd7" ref-type="disp-formula">(Equation&#x000a0;7)</xref>, <xref rid="fd8" ref-type="disp-formula">(Equation&#x000a0;8)</xref>).</p><p>(C) Comparison of quantified geometric ratios, defined in (B), for the four GelMA bioink compositions used at time zero of this study (immediately post printing). An n&#x000a0;= 5 per experimental group was used for quantitative assays. &#x02217;&#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.0001.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="p0070">Incorporation of nanostructured materials into scaffolding biomaterials has been frequently used to tune or enhance the mechanical properties of engineered tissues (<xref rid="bib13" ref-type="bibr">Corona-Gomez et&#x000a0;al., 2016</xref>; <xref rid="bib22" ref-type="bibr">Hasan et&#x000a0;al., 2018</xref>; <xref rid="bib66" ref-type="bibr">Shokouhimehr et&#x000a0;al., 2021</xref>). To examine the effect of SPIONs on the mechanical properties of GelMA constructs, we conducted unconfined uniaxial compression and microindentation tests (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>, <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S2</xref>). Unconfined compression demonstrated relatively high levels of elasticity for the control (no SPIONs) and SPION-loaded GelMA constructs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A). Incorporation of SPIONs into the bioink resulted in a decrease in the compressive modulus of bioprinted constructs which became significantly lower in the 500&#x000a0;&#x003bc;g/mL SPIONs group (32.0&#x000a0;&#x000b1; 5.0&#x000a0;kPa) in comparison to the control GelMA group (49.0&#x000a0;&#x000b1; 14.0&#x000a0;kPa) <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B). Microindentation tests showed a similar trend in the elasticity of SPION-free and SPION-loaded constructs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). Consistent with the compressive test, the elastic moduli measurements obtained from indentation showed a decreasing trend in the moduli by increasing the dose of SPIONs in the bioink, ranging from 143.8&#x000a0;&#x000b1; 24.5&#x000a0;kPa (no SPIONs) to 100.8&#x000a0;&#x000b1; 20.2&#x000a0;kPa (100&#x000a0;&#x003bc;g/mL SPIONs) (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). Of note, however, the 500&#x000a0;&#x003bc;g/mL SPIONs group showed no significant difference in moduli (126.5&#x000a0;&#x000b1; 12.5&#x000a0;kPa) in comparison to the GelMA control.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Mechanical characterization of bioprinted constructs loaded with varying quantities of superparamagnetic iron oxide nanoparticles (SPIONs)</p><p>(A and B) Unconfined compression test conducted (at a 50% total strain at 20&#x000a0;&#x003bc;m/s) on bioprinted GelMA scaffolds containing no SPIONs (control), 100, 200, and 500&#x000a0;&#x003bc;g/mL SPIONs (n&#x000a0;= 4 per group). Elastic moduli (B)&#x000a0;were calculated from the slope of the stress-strain curves at the initial 0%&#x02013;20% interval.</p><p>(C and D) Microindentation tests were conducted on GelMA constructs using a 500&#x000a0;&#x003bc;m probe, with a depth of 100&#x000a0;&#x003bc;m at 2&#x000a0;&#x003bc;m/s (n&#x000a0;= 5 per group). Elastic moduli were calculated based on the force-displacement unloading curves as described in <xref rid="sec3" ref-type="sec">STAR Methods</xref> (the slope of the linear trend line at initial 5&#x02013;20%). &#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.05, &#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.01.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0075">Stiffness measurements from unconfined compression curves indicated no significant differences across four groups, and those obtained from microindentation showed significant difference in the stiffness only between control and the 100&#x000a0;&#x003bc;g/mL SPIONs groups (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>). Consistent with our previous studies (<xref rid="bib66" ref-type="bibr">Shokouhimehr et&#x000a0;al., 2021</xref>), the overall reduction in elastic moduli (and partly stiffness) of SPION-laden scaffolds can be attributed to the potential role of NPs in blocking the bonds within the GelMA polymeric backbone, partially preventing the photocrosslinking of the LAP photoinitiator. Furthermore, the SPIONs may facilitate the formation of microcracks and also inhibit the fusion of micro-extruded GelMA layers, resulting in material instability (<xref rid="bib66" ref-type="bibr">Shokouhimehr et&#x000a0;al., 2021</xref>). The noticeable differences in the measured elastic moduli and stiffness of printed samples under compression vs. microindentation test (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref> and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>) are expected due to the inherently distinct testing modalities, probing macro vs. micro-scale mechanical properties of hydrogels (<xref rid="bib41" ref-type="bibr">Miller and Morgan, 2010</xref>).</p><p id="p0080">To date, SPIONs are extensively used as contrast agent for noninvasive labeling and tracking of a variety of biological reagents, including cells, scaffolds, and therapeutic macromolecules (<xref rid="bib33" ref-type="bibr">Li et&#x000a0;al., 2013</xref>; <xref rid="bib39" ref-type="bibr">Mahmoudi et&#x000a0;al., 2011b</xref>, <xref rid="bib40" ref-type="bibr">2016</xref>; <xref rid="bib46" ref-type="bibr">Neuwelt et&#x000a0;al., 2015</xref>). In this work, we evaluated the enhanced imaging properties of bioprinted scaffolds, laden with varying concentrations of SPIONs. Magnetic resonance (MR) images of printed structures embedded in 2% agarose (simulating soft tissue) demonstrated the remarkable effect of SPIONs incorporation on the <italic>in&#x000a0;vitro</italic> MR visibility of bioprinted scaffolds (<xref rid="fig4" ref-type="fig">Figures&#x000a0;4</xref>A&#x02013;4D). T2&#x02217;-weighted MR images showed a significant contrast induced by varying concentrations of magnetic NPs within the 3D constructs (<xref rid="fig4" ref-type="fig">Figures&#x000a0;4</xref>B&#x02013;4D) in comparison to the control (no SPIONs) group (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). No noticeable differences were observed in the resulting MR contrast across four study groups. The MR imaging results obtained here demonstrate a robust potential for conducting further quantitative analyses on bioprinted constructs in the future applications. The strong imaging contrast generated by the embedded SPIONs can enable precise fidelity measurements. Furthermore, comprehensive MRI imaging can be used to generate a standard curve for varying concentrations of SPIONs. Such data can then be used to predict/measure the SPION content within a given 3D construct in a rather noninvasive manner. We are currently working on utilizing a similar approach, based on computed tomography (CT) imaging and various CT contrast agents, to enable longitudinal and noninvasive analysis of 3D bioprinted GelMA constructs (<xref rid="bib17" ref-type="bibr">Gil et&#x000a0;al., 2021</xref>).<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Magnetic resonance imaging (MRI) of 3D bioprinted constructs loaded with varying quantities of superparamagnetic iron oxide nanoparticles (SPIONs)</p><p>(A&#x02013;D) GelMA constructs laden with no SPIONs (control) (A), 100 (B), 200 (C), and 500 (D) &#x003bc;g/mL SPIONs were imaged <italic>in&#x000a0;vitro</italic> via MRI. T1 weighted images from top (<bold>coronal, left</bold>) and T2&#x02217; weighted images from side (<bold>axial, right</bold>) demonstrated the resulting significant contrast in the magnetic 3D scaffolds. Inset in panel (A, top left) shows the 3D CAD design used to bioprint the scaffolds. Scale bars represent 10&#x000a0;mm.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0085">To evaluate the potential cytotoxic effect of SPIONs, a human umbilical vein cell (HUVEC) line and the NIH3T3 fibroblast cell line were seeded in a 2D environment (tissue culture plastic) with no SPIONs (control), or with 100, 200, or 500&#x000a0;&#x003bc;g/mL of SPIONs in the media. These two cell types were selected as some of the most commonly used cells in various tissue engineering and 3D bioprinting applications (<xref rid="bib10" ref-type="bibr">Cetnar et&#x000a0;al., 2019</xref>; <xref rid="bib44" ref-type="bibr">Naderi et&#x000a0;al., 2011</xref>; <xref rid="bib60" ref-type="bibr">Scientific, 2015</xref>; <xref rid="bib72" ref-type="bibr">Tomov et&#x000a0;al., 2019b</xref>). All AlamarBlue readouts were normalized by the day 1 data for each group. In 2D culture, the SPION-free group showed a 5-fold significant increase in HUVEC viability and growth at day 7 (p&#x000a0;&#x0003c;&#x000a0;0.0001), while the HUVECs cultured with varying concentrations of SPIONs all exhibited a significant decrease (p&#x000a0;&#x0003c;&#x000a0;0.0001) (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A). The NIH3T3 cells seeded in 2D showed an increase in cell viability and growth over time in the control (no SPIONs) and the 500&#x000a0;&#x003bc;g/mL SPIONs groups <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). Interestingly, there were no significant decreases in cell viability at day 7 for the NIH3T3 cells in contrast to the HUVEC results, suggesting greater tolerance of the fibroblast line against the NP-associated cytotoxic effects (as reported before (<xref rid="bib27" ref-type="bibr">Kong et&#x000a0;al., 2011</xref>; <xref rid="bib58" ref-type="bibr">Sahu et&#x000a0;al., 2016</xref>)). Of note, in both EC and fibroblast cells, clathrin and caveolae-mediated endocytosis are the common receptors used for the uptake of NPs, including the SPIONs (<xref rid="bib7" ref-type="bibr">Behzadi et&#x000a0;al., 2017</xref>; <xref rid="bib54" ref-type="bibr">Pottler et&#x000a0;al., 2017</xref>; <xref rid="bib56" ref-type="bibr">Rejman et&#x000a0;al., 2004</xref>; <xref rid="bib59" ref-type="bibr">Salingova et&#x000a0;al., 2019</xref>). Thus, the SPION uptake in these cells can be regulated by manipulating these cell receptor pathways, as well as tuning the NP properties (e.g., size, protein corona, and surface charge) (<xref rid="bib7" ref-type="bibr">Behzadi et&#x000a0;al., 2017</xref>; <xref rid="bib56" ref-type="bibr">Rejman et&#x000a0;al., 2004</xref>).<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Evaluating cytotoxic effect of varying concentrations of superparamagnetic iron oxide nanoparticles (SPIONs) on cells in 2D and 3D conditions</p><p>(A and B) Evaluating the SPIONs cytotoxicity effect on HUVECs in 2D (A)&#x000a0;and 3D bioprinted GelMA constructs (B). AlamarBlue reduction was quantified and normalized by the readout at day 1 for each group, as a measure of cell viability and growth (metabolic activity). Study groups included: no SPIONs (control), 100, 200, and 500&#x000a0;&#x003bc;g/mL SPIONs (n&#x000a0;= 4 per group).</p><p>(C and D) AlamarBlue analysis of NIH3T3 fibroblasts cultured with varying concentrations of SPIONs in 2D (in culture media, C) and 3D bioprinted GelMA constructs (embedded within GelMA, D) (n&#x000a0;= 4 per group).</p><p>(E and F) Immunohistochemical imaging of 3D bioprinted GelMA scaffolds following 7&#x000a0;days of 3D culture of HUVECs (E)&#x000a0;and fibroblasts (F). In panel (E), HUVECs are cytoplasmic GFP positive (green) and DAPI stained nuclei (blue). In panel (F), F-actin (red) and DAPI (blue) staining were used. Scale bars in E and F represent 100 and 200&#x000a0;&#x003bc;m, respectively. &#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.05, &#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.01, &#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.001, and &#x02217;&#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.0001. Asterisks in color indicate statistical significance for each group in comparison to the prior time point.</p></caption><graphic xlink:href="gr5"/></fig></p><p id="p0090">Cytotoxicity effects were also studied in the 3D bioprinted GelMA constructs for up to 14&#x000a0;days (<xref rid="fig5" ref-type="fig">Figures&#x000a0;5</xref>C and 5D). Both HUVECs and fibroblast cells were seeded into the 3D constructs post bioprinting and crosslinking. HUVECs showed high viablility on the SPION-free, as well as the 100 and 200&#x000a0;&#x003bc;g/mL SPIONs constructs, with a maximum viability at day 10 (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). Most favorable 3D substrates for HUVEC viability and proliferation were the control and 200&#x000a0;&#x003bc;g/mL SPION-laden GelMA constructs. NIH3T3 fibroblasts displayed a similar trend in 3D conditions with a maximum cell viability at day 10 (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D). At day 14, fibroblasts in the 500&#x000a0;&#x003bc;g/mL SPIONs group showed significantly lower viability than the other SPION-laden and SPION-free groups. Overall, the 200&#x000a0;&#x003bc;g/mL SPIONs group demonstrated the optimal support for cell viability and growth, while also providing adequate levels of printing fidelity (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>), mechanical properties (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>), and MRI contrast (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>). The increased AlamarBlue readout in the 200&#x000a0;&#x003bc;g/mL groups for both cell types could be related to the increased cell metabolic activity to uptake the SPIONs (as reported before (<xref rid="bib66" ref-type="bibr">Shokouhimehr et&#x000a0;al., 2021</xref>)), while there is still no significant toxicity exerted by these particles. The noticeable difference observed in the 2D vs. 3D cell toxicity in response to SPION exposure (<xref rid="fig5" ref-type="fig">Figures&#x000a0;5</xref>A&#x02013;5D) can be attributed to the significant effect of 3D bioprinted GelMA scaffold in sequestering the embedded SPIONs within the 3D bioink, hence, limiting/controlling the cytotoxic effect on cells.</p><p id="p0095">Immunohistochemical staining and confocal imaging of bioprinted constructs following 7&#x000a0;days of 3D culture demonstrated significant cellularization of GelMA material with HUVECs (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E) and fibroblasts (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>F). Both EC and fibroblast cells grew a multilayer coating onto the bioprinted GelMA scaffolds and demonstrated adequate attachment and morphology. In particular, ECs formed a rather continuous endothelium-like structure onto the porous structure <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E).</p><p id="p0100">Scaffold biomaterial-associated infection, with pathogens such as <italic>S.&#x000a0;aureus</italic> (<xref rid="bib19" ref-type="bibr">Gristina, 1987</xref>), is a significant hurdle that has limited clinical applications of tissue-engineered implants (<xref rid="bib15" ref-type="bibr">Darouiche, 2004</xref>; <xref rid="bib25" ref-type="bibr">Johnson and Garcia, 2015</xref>; <xref rid="bib55" ref-type="bibr">Qiu et&#x000a0;al., 2007</xref>). While current strategies to prevent such infections, including antibiotic therapies, have been helpful, there still remain multiple challenges. Bacteria continuously develop resistance against common antibacterial agents (<italic>e.g.</italic>, antibiotics) (<xref rid="bib69" ref-type="bibr">Speert, 1996</xref>). Other drawbacks for conventional antimicrobial agents are the adverse side effects, primarily an intolerable toxicity (<xref rid="bib14" ref-type="bibr">Damour et&#x000a0;al., 1992</xref>; <xref rid="bib43" ref-type="bibr">Mohamed et&#x000a0;al., 2018</xref>). Thus, alternative strategies to treat biomaterial-associated bacterial infections have been developed. Among them, NPs have emerged as novel and highly effective antimicrobial agents, owing to their high surface area to volume ratio, which confers them distinct properties (<xref rid="bib38" ref-type="bibr">Mahmoudi and Serpooshan, 2012</xref>; <xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>; <xref rid="bib77" ref-type="bibr">Wang et&#x000a0;al., 2017</xref>). Multiple types of antimicrobial NPs, including SPIONs (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>; <xref rid="bib70" ref-type="bibr">Taylor et&#x000a0;al., 2012</xref>), have shown great efficacy in treating infectious diseases, including antibiotic-resistant ones (<xref rid="bib20" ref-type="bibr">Hajipour et&#x000a0;al., 2012</xref>; <xref rid="bib77" ref-type="bibr">Wang et&#x000a0;al., 2017</xref>). In this study, for the first time, we examined the incorporation of SPIONs into GelMA bioinks as a novel approach to 3D bioprint antibacterial (i.e., bacteriostatic) scaffold systems. Bioprinted constructs were seeded with a luminescent <italic>S.&#x000a0;aureus</italic> strain to assess the antibacterial effects (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>). Embedded SPIONs within the constructs resulted in significant reduction of <italic>S.&#x000a0;aureus</italic> bacteria, particularly in the 200 and 500&#x000a0;&#x003bc;g/mL SPION groups which showed 31% and 45% reductions in luminescence intensity, respectively, in comparison to the 3D control (<xref rid="fig6" ref-type="fig">Figures&#x000a0;6</xref>A and 6B). Of note, 3D printed GelMA constructs without SPIONs showed slightly (not significant) higher levels of bacterial activity and growth (&#x0223c;26%) when compared to the 2D culture, which suggests the favorable environment of 3D scaffolds to grow bacteria as reported before (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>). In comparison to the 3D constructs without SPIONs, the 500&#x000a0;&#x003bc;g/mL SPION group showed &#x0223c;57% reduction in bacteria growth (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B). The percentages of reduction in bacteria count reported here are consistent with previous reports (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>; <xref rid="bib66" ref-type="bibr">Shokouhimehr et&#x000a0;al., 2021</xref>), indicating a &#x0223c;20%&#x02013;40% reduction in bacterial growth, when comparable levels of SPIONs were incorporated into 3D scaffold systems. Thus, while such solutions do not fully eradicate bacteria in 3D culture, they are primarily proposed as a <italic>preventive measure</italic> to stop the initiation of bacterial films and control their growth in 3D scaffolds (<xref rid="bib20" ref-type="bibr">Hajipour et&#x000a0;al., 2012</xref>).<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Evaluating bacteriostatic effect of superparamagnetic iron oxide nanoparticles (SPIONs) in 2D cultures and 3D bioprinted scaffold systems</p><p>(A and B) Evaluating the antibacterial effect of varying concentrations of SPIONs in 2D culture (control) and 3D bioprinted GelMA scaffolds, seeded with luminescent <italic>S.&#x000a0;aureus</italic> bacteria. Luminescence imaging of 2D controls and 3D printed constructs was performed after 24&#x000a0;h of incubation with bacteria (A)&#x000a0;and the signal intensity was quantified and normalized based on the 2D control without SPIONs (B). Sample size (<italic>n</italic>)&#x000a0;= 4 per group.</p><p>(C&#x02013;E) We subsequently assessed the antibacterial function of nanoparticles in a cellular 3D culture of endothelial cells (ECs), simulating bacterial infection of <italic>in&#x000a0;vitro</italic> culture specimens. AlamarBlue assay was performed on days 3 and 5, pre and post 24-h incubation of <italic>S.&#x000a0;aureus</italic> to assess the effect of bacteria on EC viability and growth (C). At day 5, luminescence imaging was performed (D)&#x000a0;and quantified (E)&#x000a0;to examine the effect of incorporated SPIONs in inhibiting bacterial infection within the 3D bioprinted constructs. Sample size (<italic>n</italic>)&#x000a0;= 4 per group.</p><p>(F) Confocal imaging of immunostained tissue slices at day 5, after 24&#x000a0;h of EC- <italic>S.&#x000a0;aureus</italic> coculture, highlighting the colocalization of bacterial within 3D EC clusters in the GelMA matrix. Samples were sectioned and stained with anti-CD31 (green, ECs), anti-<italic>Staphylococcus aureus</italic> (red, bacteria), and DAPI (blue, nuclei). Red arrows point to localization of bacteria within the EC clusters in the 3D structures. Scale bars in (F) represent 100 &#x003bc;m. &#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.05, &#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.01, &#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.001, and &#x02217;&#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.0001. Asterisks in color indicate statistical significance for each group in comparison to the prior time point.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0105">We subsequently simulated the bacterial infection of 3D HUVEC cultures in bioprinted GelMA constructs (<xref rid="fig6" ref-type="fig">Figures&#x000a0;6</xref>C&#x02013;6E). On day 3, prior to addition of bacteria, AlamarBlue results demonstrated higher (significant for the 100&#x000a0;&#x003bc;g/mL group) EC viability and growth after 3&#x000a0;days of culture in the SPION-laden groups compared to the 3D control (empty GelMA) (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). This confirmed the cytocompatibility of SPIONs at the selected concentrations while embedded within the 3D matrix (<xref rid="bib57" ref-type="bibr">Saei et&#x000a0;al., 2017</xref>; <xref rid="bib78" ref-type="bibr">Wei et&#x000a0;al., 2021</xref>). The increase in EC viability/growth observed here for the 100&#x000a0;&#x003bc;g/mL was not obtained in the prior cytotoxicity assay (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). This rather small difference may be related to the inherent, slight variability of the AlamarBlue assay and the fluorescence readouts. On day 5, after 24&#x000a0;h of incubation with bacteria, there was a clear increase of AlamarBlue activity in the control GelMA constructs (without SPIONs) containing <italic>S.&#x000a0;aureus</italic> bacteria, compared to those without the bacteria. This is attributed to the boosting effect of grown bacteria on reducing the AlamarBlue reagent (resazurin), as also evidenced in the contaminated cell cultures and other biological processes (e.g., milk contamination (<xref rid="bib50" ref-type="bibr">O'Brien et&#x000a0;al., 2000</xref>)). EC coculture with <italic>S.&#x000a0;aureus</italic> in the constructs containing SPIONs showed a decrease in AlamarBlue readout at day 5. The 200 and 500&#x000a0;&#x003bc;g/mL SPION groups both demonstrated a significant (p&#x000a0;&#x0003c;&#x000a0;0.0001) &#x0223c;41% decrease in AlamarBlue reduction which could be mainly attributed to the antibacterial function of SPIONs and the removal of bacteria. This is while the EC culture without <italic>S.&#x000a0;aureus</italic> showed slightly higher or equal levels of cell viability and growth at day 5 (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). To further investigate the bacteriostatic effect, we examined the luminescence signal of the <italic>S.&#x000a0;aureus</italic> bacteria that were added to ongoing cultures on day 4. Significantly (p&#x000a0;&#x0003c;&#x000a0;0.0001) distinct growth was observed after 24&#x000a0;h in the SPION-free control group versus the constructs loaded with varying levels of SPIONs (<xref rid="fig6" ref-type="fig">Figures&#x000a0;6</xref>D and 6E). By increasing the SPION concentration in the bioinks, the 100, 200, and 500&#x000a0;&#x003bc;g/mL SPION groups exhibited amplified bacteriostatic effects, resulting in 29%, 34%, and 33% decreases in the bacteria signal, respectively.</p><p id="p0110">Immunohistochemical analysis of infected 3D constructs, after 24&#x000a0;h of incubation with <italic>S.&#x000a0;aureus</italic>, revealed that the ECs remained viable and adherent to the 3D matrix, while the bacteria colonies colocalized with the EC clusters (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>F). The formation of <italic>S.&#x000a0;aureus</italic> biofilm was evident in the SPION-free control group, as well as some smaller areas in the SPION-laden constructs (red arrows, <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>F). Confocal imaging of the 500&#x000a0;&#x003bc;g/mL SPION group shows notably lower number of ECs, as well as bacteria, in the 3D constructs which is in agreement with the cytotoxicity results obtained via AlamarBlue assays (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>). Overall, these results confirmed that the 200&#x000a0;&#x003bc;g/mL SPION-laden bioprints demonstrate the optimal functions (e.g., printability, cell viability and growth, mechanical properties, MRI contrast, and antibacterial effects) for <italic>in&#x000a0;vitro</italic> modeling and screening applications, as well as use as implants for a variety of regenerative medicine applications.</p><sec id="sec2.1"><title>Conclusions</title><p id="p0115">This work demonstrated, for the first time, the use of engineered NP systems to develop a new class of hydrogel-based bioinks with enhanced antibacterial and imaging properties, while maintaining their printability and printing fidelity, mechanical properties, and bioactivity. The 3D bioprinted SPION-laden hydrogel constructs developed here can be used in a variety of soft and hard tissue engineering applications. Through preventing the biofilm formation, and simultaneously enabling longitudinal noninvasive tracking of the scaffolds, these engineered scaffolds would help alleviate several major complications related to biomaterial implants, particularly reducing the risk of implant infection and rejection. While our results suggest that a 200&#x000a0;&#x003bc;g/mL of SPIONs encapsulated in the GelMA bioink yields optimal <italic>in&#x000a0;vitro</italic> functions of the scaffolds, the concentration and properties of NP systems will further require tuning for each specific NP type, hydrogel material, bacteria strain, and also for the specific biomedical application. Integrating these new functions of SPION-laden bioinks with the established advantages of bioprinting methods, such as patient/damage specificity and heterogeneous structures, would enable creation of robust multifunctional platforms for diverse clinical and translational applications.</p><p id="p0120">Future studies could investigate the interplay between incorporated NPs with the immune system cells, such as macrophages and T&#x000a0;cells, and its role in the elicited antibacterial effects as well as other functions of the bioprinted scaffold systems. Furthermore, incorporation of functional and tissue/patient-specific cells types, such as induced pluripotent stem cell-derived cardiomyocytes, within the NP-laden bioinks can usher in a new wave of personalized precision regenerative therapies.</p></sec><sec id="sec2.2"><title>Limitations of the study</title><p id="p0125">Integration of functionalized antibacterial nanoparticles with microextrusion-based 3D bioprinting is one of the first attempts to generate antibacterial bioink formulations for antibacterial scaffold biofabrication. This research could still benefit from more in-depth characterization of the nanoparticle-bacteria interactions within the 3D structure. While this study showed relative success of the SPION-laden bioinks in inhibiting bacteria growth, a complete eradication of the bacteria was not achieved. Analysis and optimization of the SPIONs properties and encapsulation strategies (e.g., altering the particles composition, surface coating, and electrical charge to change affinity with the hydrogel bioink) could further improve the efficacy of the antibacterial properties. Furthermore, studying the potential impact of the released particles on cell/tissue response (e.g., cytotoxicity and clearance) in both <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic> settings would be of great significance to assess the capacity of engineered bioinks for translation into clinical applications.</p></sec></sec><sec id="sec3"><title>STAR&#x02605;Methods</title><sec id="sec3.1"><title>Key resources table</title><p id="p0130">
<table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>anti-CD31</td><td>Invitrogen&#x02122;</td><td>Cat: MA3100; RRID:<ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_223516" id="interref25">AB_223516</ext-link></td></tr><tr><td>anti-connexin43</td><td>Invitrogen&#x02122;</td><td>Cat: 71-070-0; RRID:<ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2533973" id="interref30">AB_2533973</ext-link></td></tr><tr><td>polyclonal anti-<italic>Staphylococcus aureus</italic></td><td>BioRad</td><td>Cat: 0300-0084; RRID:<ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_619560" id="interref35">AB_619560</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Bacterial and virus strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><italic>Staphylococcus aureus</italic></td><td>ATCC</td><td>Cat:43300; RRID:WB-STRAIN:WBStrain00041949</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Methacrylic anhydride</td><td>Millipore Sigma</td><td>Cas: 760-93-0</td></tr><tr><td>lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP)</td><td>Millipore Sigma</td><td>Cas: 85073-19-4</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Experimental models: Cell lines</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>human umbilical vein endothelial cell (HUVEC)</td><td>Lifeline Technology</td><td>Cat: FC-0044</td></tr><tr><td>NIH-3T3</td><td>ATCC</td><td>Cat: CRL-1658; RRID:CVCL_0594</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Autodesk Fusion 360</td><td>Autodesk Inc., San Rafael, CA</td><td/></tr><tr><td>ImageJ</td><td>National Institutes of Health, USA</td><td/></tr><tr><td>JMP</td><td>JMP Statistical Discovery, SAS, USA</td><td/></tr></tbody></table></table-wrap>
</p></sec><sec id="sec3.2"><title>Resource availability</title><sec id="sec3.2.1"><title>Lead contact</title><p id="p0135">Further information and requests should be directed to and will be fulfilled by the Lead Contact, Vahid Serpooshan at <ext-link ext-link-type="uri" xlink:href="mailto:vahid.serpooshan@bme.gatech.edu" id="intref0010">vahid.serpooshan@bme.gatech.edu</ext-link>.</p></sec><sec id="sec3.2.2"><title>Materials availability</title><p id="p0140">This study did not generate new unique reagents.</p></sec></sec><sec id="sec3.3"><title>Experimental model and subject details</title><p id="p0145">Details of the bioprinted <italic>in&#x000a0;vitro</italic> model and cell culture model are completely described in <xref rid="sec3.4" ref-type="sec">method details</xref>.</p></sec><sec id="sec3.4"><title>Method details</title><sec id="sec3.4.1"><title>3D bioprinting of constructs</title><p id="p0150">3D constructs were prepared using GelMA synthesized from porcine gelatin type A and methacrylic anhydride (MA) as described before (88.9&#x000a0;&#x000b1; 1.0% methacrylation degree) (<xref rid="bib47" ref-type="bibr">Ning et&#x000a0;al., 2020</xref>; <xref rid="bib65" ref-type="bibr">Shirahama et&#x000a0;al., 2016</xref>). SPIONs were purchased (Micromod Partikeltechnologie GmbH, Rostock, Germany) and incorporated into the GelMA bioink to obtain concentrations of 100&#x000a0;&#x003bc;g/mL, 200&#x000a0;&#x003bc;g/mL, and 500&#x000a0;&#x003bc;g/mL of NPs while maintaining the overall weight percentage of GelMA at 10% (g/mL). A 0.5% (w/v) concentration of lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was used as a photoinitiator to crosslink the bioinks under a 10 mW/cm<sup>2</sup> UV light source for 2&#x000a0;min. These crosslinking parameters were chosen based on our previous experiences (<xref rid="bib32" ref-type="bibr">Li et&#x000a0;al., 2022</xref>; <xref rid="bib42" ref-type="bibr">ML Tomov et&#x000a0;al., 2019</xref>; <xref rid="bib47" ref-type="bibr">Ning et&#x000a0;al., 2020</xref>; <xref rid="bib48" ref-type="bibr">Ning et&#x000a0;al., 2022</xref>; <xref rid="bib49" ref-type="bibr">Ning et&#x000a0;al., 2021</xref>) to generate GelMA constructs at biologically relevant stiffness (mimicking soft tissue stiffness, &#x0223c;20&#x02013;140&#x000a0;kPa (<xref rid="bib24" ref-type="bibr">Huang et&#x000a0;al., 2012</xref>; <xref rid="bib63" ref-type="bibr">Serpooshan et&#x000a0;al., 2013</xref>; <xref rid="bib79" ref-type="bibr">Wei et&#x000a0;al., 2015</xref>)). 3D printed constructs were designed using Autodesk Fusion 360 CAD software (Autodesk Inc., San Rafael, CA) and converted to the standard STL file format for printing. Constructs were printed utilizing a BioAssemblyBot robotic arm 3D bioprinter (Advanced Solutions Life Sciences, Louisville, KY). One standard geometry was used for <italic>in&#x000a0;vitro</italic> experiments. The scaffold geometry featured a 12&#x000a0;&#x000d7;&#x000a0;12&#x000a0;&#x000d7;&#x000a0;4&#x000a0;mm<sup>3</sup> structure with an internal lattice structure with a pore size of 1&#x000a0;mm. This model was used for all <italic>in&#x000a0;vitro</italic> cytotoxicity experiments, bacteria studies, and MR imaging. Bioprinting parameters used consistently to print all GelMA constructs for this study included: printing speed of 5&#x000a0;mm/s, pressure of 20 psi, temperature of 27&#x000b0;C, layer height of 0.2&#x000a0;mm, and a 27-gauge syringe needle.</p></sec><sec id="sec3.4.2"><title>Fidelity measurements</title><p id="p0155">To assess fidelity of various bioinks developed in this study, we 3D bioprinted a simple two-layer cross hatch design and examined the accuracy of several geometric parameters. Bright-field microscopy images were acquired at 1.5X and 4&#x000d7; magnifications to assess the printing fidelity using ImageJ (National Institutes of Health, USA). Design factors such as the strand diameter ratio, strand uniformity ratio, strand angle ratio, and inter-strand area ratio were quantified as described before (<xref rid="bib47" ref-type="bibr">Ning et&#x000a0;al., 2020</xref>). In the CAD model, we used a strand diameter (<inline-formula><mml:math id="M16" altimg="si5.gif"><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:math></inline-formula>) of 0.3&#x000a0;mm, a length of strand (<inline-formula><mml:math id="M17" altimg="si6.gif"><mml:mrow><mml:mi>U</mml:mi></mml:mrow></mml:math></inline-formula>) of 9&#x000a0;mm, a strand angle (<inline-formula><mml:math id="M18" altimg="si7.gif"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>) of 60&#x000b0;, and an inter-strand area (<inline-formula><mml:math id="M19" altimg="si8.gif"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:math></inline-formula>) of 1&#x000a0;mm<sup>2</sup>. These reference values were compared against the ones measured in the printed 2-layer structure to obtain the normalized ratios. These ratios are defined as the strand diameter (<inline-formula><mml:math id="M20" altimg="si1.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), strand uniformity (<inline-formula><mml:math id="M21" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), strand angle (<inline-formula><mml:math id="M22" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), and inter-strand area (<inline-formula><mml:math id="M23" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) ratios, obtained using <xref rid="fd5" ref-type="disp-formula">Equations (5)&#x02013;(8)</xref>. ImageJ was used to perform and record all measurements.<disp-formula id="fd5"><label>(Equation&#x000a0;5)</label><mml:math id="M24" altimg="si9.gif"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.25em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>D</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.25em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"/><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>200</mml:mn><mml:mspace width="0.25em"/><mml:mo>&#x003bc;</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="fd6"><label>(Equation&#x000a0;6)</label><mml:math id="M25" altimg="si10.gif"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width="0.25em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>L</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width="0.25em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"/><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>L</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1.5</mml:mn><mml:mspace width="0.25em"/><mml:mi>m</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="fd7"><label>(Equation&#x000a0;7)</label><mml:math id="M26" altimg="si11.gif"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mi>A</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.25em"/><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>o</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.25em"/><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>o</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mo linebreak="badbreak">=</mml:mo><mml:mspace width="0.25em"/><mml:msup><mml:mn>60</mml:mn><mml:mi>o</mml:mi></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="fd8"><label>(Equation&#x000a0;8)</label><mml:math id="M27" altimg="si12.gif"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mi>A</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>f</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>A</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>f</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.25em"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>A</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mo linebreak="badbreak">=</mml:mo><mml:mspace width="0.25em"/><mml:mn>1.95</mml:mn><mml:mspace width="0.25em"/><mml:mi>m</mml:mi><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="p0160">Each fidelity test was repeated five times and three bright field microscopy images were acquired (randomly) from each construct and manually measured (n&#x000a0;= 15).</p></sec><sec id="sec3.4.3"><title>Mechanical testing</title><p id="p0165">Uniaxial unconfined compression and microindentation tests were performed on 3D printed cubic structures (7&#x000a0;&#x000d7;&#x000a0;7&#x000a0;&#x000d7;&#x000a0;4&#x000a0;mm<sup>3</sup>) composed of 10% (w/v) GelMA together with 100, 200, or 500&#x000a0;&#x003bc;g/mL SPIONs. A&#x000a0;Mach-1 mechanical testing system (Biomomentum, QC, Canada) was utilized for the tests. Unconfined compression was conducted at a 50% total strain at 20&#x000a0;&#x003bc;m/s. The compressive modulus was derived from the slope of the linear trend line (initial 0&#x02013;20%) of the stress-strain curve. Four replicates were prepared (n&#x000a0;= 4) and the average value with standard deviation was recorded.</p><p id="p0170">The localized mechanical behavior of printed constructs was further assessed using microindentation. A 500&#x000a0;&#x003bc;m probe was used to indent the surface of each construct (n&#x000a0;= 5), with a depth of 100&#x000a0;&#x003bc;m at 2&#x000a0;&#x003bc;m/s. The force-displacement unloading curves were plotted and used to calculate the stiffness of the sample (<inline-formula><mml:math id="M28" altimg="si13.gif"><mml:mrow><mml:mtext>S</mml:mtext></mml:mrow></mml:math></inline-formula>) from the linear trend line slope (initial 5&#x02013;20%), and the reduced elastic modulus <inline-formula><mml:math id="M29" altimg="si14.gif"><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mtext>E</mml:mtext><mml:mtext>r</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> was next derived using the equation below (<xref rid="bib53" ref-type="bibr">Oliver and Pharr, 2004</xref>):<disp-formula id="fd1"><label>(Equation&#x000a0;1)</label><mml:math id="M30" altimg="si15.gif"><mml:mrow><mml:msub><mml:mtext>E</mml:mtext><mml:mtext>r</mml:mtext></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:msqrt><mml:mtext>&#x003c0;</mml:mtext></mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mtext>&#x003b2;</mml:mtext></mml:mrow></mml:mfrac><mml:mfrac><mml:mtext>S</mml:mtext><mml:msqrt><mml:mrow><mml:mtext>A</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msqrt></mml:mfrac></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M31" altimg="si16.gif"><mml:mrow><mml:mtext>&#x003b2;</mml:mtext></mml:mrow></mml:math></inline-formula> is a constant and equals 1 in this study and <inline-formula><mml:math id="M32" altimg="si17.gif"><mml:mrow><mml:mtext>&#x000a0;A</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is projected contact area at the contact depth of <inline-formula><mml:math id="M33" altimg="si18.gif"><mml:mrow><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub></mml:mrow></mml:math></inline-formula>, which can be obtained from the following equation:<disp-formula id="fd2"><label>(Equation&#x000a0;2)</label><mml:math id="M34" altimg="si19.gif"><mml:mrow><mml:mtext>A</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mtext>Rh</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mtext>&#x000a0;&#x003c0;</mml:mtext><mml:msup><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></disp-formula>where<disp-formula id="fd3"><label>(Equation&#x000a0;3)</label><mml:math id="M35" altimg="si20.gif"><mml:mrow><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mtext>&#x000a0;h</mml:mtext><mml:mtext>max</mml:mtext></mml:msub><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mtext>&#x000a0;&#x003b5;</mml:mtext><mml:mfrac><mml:msub><mml:mtext>P</mml:mtext><mml:mtext>max</mml:mtext></mml:msub><mml:mtext>S</mml:mtext></mml:mfrac></mml:mrow></mml:math></disp-formula><inline-formula><mml:math id="M36" altimg="si21.gif"><mml:mrow><mml:msub><mml:mtext>h</mml:mtext><mml:mtext>max</mml:mtext></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M37" altimg="si22.gif"><mml:mrow><mml:msub><mml:mtext>P</mml:mtext><mml:mtext>max</mml:mtext></mml:msub></mml:mrow></mml:math></inline-formula> are the peak unloading displacement and unloading force, respectively, and <inline-formula><mml:math id="M38" altimg="si23.gif"><mml:mrow><mml:mtext>&#x003b5;</mml:mtext></mml:mrow></mml:math></inline-formula> is a constant with a value of 0.75 for a spherical probe (<xref rid="bib52" ref-type="bibr">Oliver and Pharr, 1992</xref>).</p><p id="p0175">The elastic modulus, <inline-formula><mml:math id="M39" altimg="si24.gif"><mml:mrow><mml:mtext>E</mml:mtext></mml:mrow></mml:math></inline-formula>, can be then calculated from using the <xref rid="fd4" ref-type="disp-formula">Equation&#x000a0;(4)</xref> (<xref rid="bib53" ref-type="bibr">Oliver and Pharr, 2004</xref>):<disp-formula id="fd4"><label>(Equation&#x000a0;4)</label><mml:math id="M40" altimg="si25.gif"><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mtext>E</mml:mtext><mml:mtext>r</mml:mtext></mml:msub></mml:mfrac><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msup><mml:mtext>v</mml:mtext><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>E</mml:mtext></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msubsup><mml:mtext>v</mml:mtext><mml:mtext>i</mml:mtext><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:msub><mml:mtext>E</mml:mtext><mml:mtext>i</mml:mtext></mml:msub></mml:mfrac></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M41" altimg="si26.gif"><mml:mrow><mml:mtext>v</mml:mtext></mml:mrow></mml:math></inline-formula> is the Poisson&#x02019;s ratio of tested material with a value of 0.5 and <inline-formula><mml:math id="M42" altimg="si27.gif"><mml:mrow><mml:msub><mml:mtext>v</mml:mtext><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></inline-formula> is 0.5 for the indenter tip material. <inline-formula><mml:math id="M43" altimg="si28.gif"><mml:mrow><mml:msub><mml:mtext>E</mml:mtext><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></inline-formula> represents the elastic modulus of the probe, with a value of 2 GPa.</p></sec><sec id="sec3.4.4"><title>MR imaging of bioprinted scaffolds</title><p id="p0180">The effect of SPION incorporation on the MR-visibility of bioprinted GelMA scaffolds was examined <italic>in&#x000a0;vitro</italic> using T2&#x02217; weighted images as described before (<xref rid="bib40" ref-type="bibr">Mahmoudi et&#x000a0;al., 2016</xref>). Briefly, bioprinted GelMA constructs containing varying concentrations of SPIONs were fixed, embedded in 2% agarose gel (<xref rid="bib5" ref-type="bibr">Baek et&#x000a0;al., 2019</xref>), and imaged using a 9.4T/20&#x000a0;cm Bruker animal MR imaging/spectroscopy system driven by LINUX workstation and Bruker ParaVision 5.1 imaging software (<xref rid="bib34" ref-type="bibr">Magnuson et&#x000a0;al., 2010</xref>).</p></sec><sec id="sec3.4.5"><title>Endothelial and NIH3T3cell culture</title><p id="p0185">A well characterized human umbilical vein endothelial cell (HUVEC) line was purchased (Lifeline Cell Technology LLC, USA) and used for the <italic>in&#x000a0;vitro</italic> cell culture experiments. The HUVECs were cultured with VascuLife VEGF Endothelial Medium Complete Kit (LL-0003) (Lifeline Cell Technology LLC, USA), with or without antibiotics and antimycotics, in T75 culture flasks in a humidified tissue culture incubator (37&#x000b0;C with a 5% CO<sub>2</sub>). 2D HUVEC cultures were seeded at a density of 10,000 cells/cm<sup>2</sup> in a 6 well plate and cultured for up to 7&#x000a0;days. A density of 2&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/construct were seeded onto 3D printed constructs and left to culture up to 5 or 14&#x000a0;days before fixation with 10% formalin. NIH 3T3 fibroblasts were cultured in 2D 10-cm Petri dishes using Eagle&#x02019;s Minimum Essential Medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (all from ATCC, USA). Following confluency, fibroblasts were dissociated and seeded onto 3D bioprinted GelMA constructs at a density of 2&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/construct.</p></sec><sec id="sec3.4.6"><title>Cell viability and growth measurements</title><p id="p0190">Cellular viability was evaluated, longitudinally and in a noninvasive manner, using the AlamarBlue Cell Viability Reagent (BioRad, USA). The AlamarBlue reagent was added to fresh media in a 1:10 volumetric ratio and added to the culture wells. The samples were left to incubate in the solution for 4 h. Subsequently, 100-&#x003bc;L supernatant samples were collected from each well and transferred to a 96-well plate in triplicates. Absorbance was recorded at 550 and 600&#x000a0;nm utilizing a microplate reader (BioTek Instruments, USA). Readings were recorded at days 3 and 7, and days 3, 7, 10, and 14 for 2D and 3D SPION cytotoxicity studies, respectively.</p><p id="p0195">To simulate bacterial infection of 3D cell culture, endothelial cells were seeded into the bioprinted GelMA constructs (2&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/construct, seeded after printing and crosslinking) at varying SPION concentrations (0, 100, 200, and 500&#x000a0;&#x003bc;g/mL) and cultured for 3&#x000a0;days. On the day 3, <italic>S.&#x000a0;aureus</italic> (<italic>S.&#x000a0;aureus</italic>; ATCC 43300) bacteria were seeded into each construct (10<sup>8</sup> colony-forming-units/construct) as described below. Following 2&#x000a0;days of coculture, constructs were imaged via luminescence imaging and then fixed and analyzed via immunohistochemistry as explained below. AlamarBlue assay was conducted at days 3 and 5 as above.</p></sec><sec id="sec3.4.7"><title>Bacteria cultures and assays</title><p id="p0200"><italic>S.&#x000a0;aureus</italic> (<italic>S.&#x000a0;aureus</italic>; ATCC 43300) was transduced with a modified <italic>luxABCDE</italic> operon from <italic>Photorhabdus luminescens</italic> optimized for Gram-positive expression (Xen29, Caliper) so that live bacteria emit bioluminescence and bacterial number can be quantified culture-independent and in real-time using a luminometer and an ICCD camera (<xref rid="bib16" ref-type="bibr">Francis et&#x000a0;al., 2001</xref>). <italic>S.&#x000a0;aureus</italic> was cultured aerobically at 37&#x000b0; in Luria&#x02013;Bertani (LB) medium (Difco) 18 h, then subcultured 1:40 to an optical density at 600&#x000a0;nm (OD<sub>600</sub>) of 0.4 via spectrophotometry. Subsequently, 10<sup>8</sup> colony-forming units of bacteria were added onto 3D printed constructs with and without SPIONs in a 24-well tissue culture plate (Costar) and co-incubated up to 24&#x000a0;h to determine remaining bacteria levels. Each plate was imaged on a ChemiDoc MP Imaging System (Bio-Rad Laboratories, USA) without external light source to specifically measure <italic>S.&#x000a0;aureus</italic> bioluminescence. The luminescence signal was quantified using the analysis software ImageJ (NIH). The area of each SPION was selected and the total signal quantified from pixel intensity within this region, then averaged between technical replicates for each group.</p></sec><sec id="sec3.4.8"><title>Immunohistochemical analysis &#x02013; Confocal microscopy</title><p id="p0205">Harvested constructs were fixed in 10% neutral buffered formalin at room temperature for 30&#x000a0;min and washed immediately with PBS (5&#x000a0;min). Constructs were then sliced with a vibratome (Leica VT 1200S) to a thickness of 200&#x000a0;&#x003bc;m for further analysis. Sections were stained with a variety of primary antibodies including anti-CD31 (#ENMA3100, Invitrogen), anti-connexin43 (#71-070-0, Invitrogen), and polyclonal anti-<italic>S.&#x000a0;aureus</italic> (#0300-0084, BioRad). Confocal imaging was performed using the Olympus FV1000 confocal laser microscope.</p></sec></sec><sec id="sec3.5"><title>Quantification and statistical analysis</title><p id="p0210">Statistical analysis was performed utilizing JMP (JMP Statistical Discovery from SAS, USA) software. Significant differences were determined with one-way ANOVA or two-way ANOVA if applicable. A post-hoc Tukey-Kramer test was performed for multiple comparisons and a p value of &#x0003c;0.05 was considered statistically significant (&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.05, &#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.01, &#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.001, and &#x02217;&#x02217;&#x02217;&#x02217; p value&#x000a0;&#x0003c;&#x000a0;0.0001). Least square means connecting letters reports were also used to show significant differences between multiple comparisons. Levels not connected by the same letter are significantly different. Levels connected by the same letter are not significantly different.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Abat</surname><given-names>C.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name><name><surname>Rolain</surname><given-names>J.M.</given-names></name></person-group><article-title>Are we living in an antibiotic resistance nightmare?</article-title><source>Clin. Microbiol. Infect.</source><volume>24</volume><year>2018</year><fpage>568</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2018.01.004</pub-id><pub-id pub-id-type="pmid">29337254</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>S.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Balla</surname><given-names>V.K.</given-names></name><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Barui</surname><given-names>A.</given-names></name><name><surname>Bodhak</surname><given-names>S.</given-names></name></person-group><article-title>Current developments in 3D bioprinting for tissue and organ regeneration&#x02013;A review</article-title><source>Front. Mech. Eng.</source><volume>6</volume><year>2020</year><pub-id pub-id-type="doi">10.3389/fmech.2020.589171</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>F.</given-names></name><name><surname>Ferreira</surname><given-names>C.A.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Cai</surname><given-names>W.</given-names></name></person-group><article-title>Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging</article-title><source>Wiley Interdiscip Rev. Nanomed. Nanobiotechnol.</source><volume>8</volume><year>2016</year><fpage>619</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1002/wnan.1386</pub-id><pub-id pub-id-type="pmid">26692551</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Albanna</surname><given-names>M.</given-names></name><name><surname>Binder</surname><given-names>K.W.</given-names></name><name><surname>Murphy</surname><given-names>S.V.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Qasem</surname><given-names>S.A.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Tan</surname><given-names>J.</given-names></name><name><surname>El-Amin</surname><given-names>I.B.</given-names></name><name><surname>Dice</surname><given-names>D.D.</given-names></name><name><surname>Marco</surname><given-names>J.</given-names></name><etal/></person-group><article-title>In situ bioprinting of autologous skin cells accelerates wound healing of extensive excisional full-thickness wounds</article-title><source>Sci. Rep.</source><volume>9</volume><year>2019</year><fpage>1856</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-38366-w</pub-id><pub-id pub-id-type="pmid">30755653</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>K.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Min</surname><given-names>E.</given-names></name><name><surname>Jung</surname><given-names>W.</given-names></name><name><surname>Cho</surname><given-names>H.</given-names></name></person-group><article-title>Quantitative assessment of regional variation in tissue clearing efficiency using optical coherence tomography (OCT) and magnetic resonance imaging (MRI): a feasibility study</article-title><source>Sci. Rep.</source><volume>9</volume><year>2019</year><fpage>2923</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-39634-z</pub-id><pub-id pub-id-type="pmid">30814611</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Bakhsheshi-Rad</surname><given-names>H.R.</given-names></name><name><surname>Ismail</surname><given-names>A.F.</given-names></name><name><surname>Aziz</surname><given-names>M.</given-names></name><name><surname>Akbari</surname><given-names>M.</given-names></name><name><surname>Hadisi</surname><given-names>Z.</given-names></name><name><surname>Daroonparvar</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.B.</given-names></name></person-group><article-title>Antibacterial activity and in&#x000a0;vivo wound healing evaluation of polycaprolactone-gelatin methacryloyl-cephalexin electrospun nanofibrous</article-title><source>Mater. Lett.</source><volume>256</volume><year>2019</year><fpage>126618</fpage><pub-id pub-id-type="doi">10.1016/j.matlet.2019.126618</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Behzadi</surname><given-names>S.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Tao</surname><given-names>W.</given-names></name><name><surname>Hamaly</surname><given-names>M.A.</given-names></name><name><surname>Alkawareek</surname><given-names>M.Y.</given-names></name><name><surname>Dreaden</surname><given-names>E.C.</given-names></name><name><surname>Brown</surname><given-names>D.</given-names></name><name><surname>Alkilany</surname><given-names>A.M.</given-names></name><name><surname>Farokhzad</surname><given-names>O.C.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Cellular uptake of nanoparticles: journey inside the cell</article-title><source>Chem. Soc. Rev.</source><volume>46</volume><year>2017</year><fpage>4218</fpage><lpage>4244</lpage><pub-id pub-id-type="doi">10.1039/c6cs00636a</pub-id><pub-id pub-id-type="pmid">28585944</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>A.</given-names></name><name><surname>Janarthanan</surname><given-names>G.</given-names></name><name><surname>Noh</surname><given-names>I.</given-names></name></person-group><article-title>Nano-biomaterials for designing functional bioinks towards complex tissue and organ regeneration in 3D bioprinting</article-title><source>Addit. Manuf.</source><volume>37</volume><year>2021</year><fpage>101639</fpage><pub-id pub-id-type="doi">10.1016/j.addma.2020.101639</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Busscher</surname><given-names>H.J.</given-names></name><name><surname>van der Mei</surname><given-names>H.C.</given-names></name><name><surname>Subbiahdoss</surname><given-names>G.</given-names></name><name><surname>Jutte</surname><given-names>P.C.</given-names></name><name><surname>van den Dungen</surname><given-names>J.J.</given-names></name><name><surname>Zaat</surname><given-names>S.A.</given-names></name><name><surname>Schultz</surname><given-names>M.J.</given-names></name><name><surname>Grainger</surname><given-names>D.W.</given-names></name></person-group><article-title>Biomaterial-associated infection: locating the finish line in the race for the surface</article-title><source>Sci. Transl. Med.</source><volume>4</volume><year>2012</year><fpage>153rv110</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3004528</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="book" id="sref10"><person-group person-group-type="author"><name><surname>Cetnar</surname><given-names>A.</given-names></name><name><surname>Tomov</surname><given-names>M.</given-names></name><name><surname>Theus</surname><given-names>A.</given-names></name><name><surname>Lima</surname><given-names>B.</given-names></name><name><surname>Vaidya</surname><given-names>A.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><part-title>3D bioprinting in clinical cardiovascular medicine</part-title><person-group person-group-type="editor"><name><surname>Guvendiren</surname><given-names>M.</given-names></name></person-group><source>3D Bioprinting in Medicine: Technologies, Bioinks, and Applications</source><year>2019</year><publisher-name>Springer International Publishing</publisher-name><fpage>149</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-23906-0_5</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>W.W.</given-names></name><name><surname>Yeo</surname><given-names>D.C.L.</given-names></name><name><surname>Tan</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Choudhury</surname><given-names>D.</given-names></name><name><surname>Naing</surname><given-names>M.W.</given-names></name></person-group><article-title>Additive biomanufacturing with collagen inks</article-title><source>Bioengineering (Basel)</source><volume>7</volume><year>2020</year><pub-id pub-id-type="doi">10.3390/bioengineering7030066</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>J.J.</given-names></name><name><surname>Im</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>J.W.</given-names></name><name><surname>Jung</surname><given-names>Y.</given-names></name></person-group><article-title>Toward biomimetic scaffolds for tissue engineering: 3D printing techniques in regenerative medicine</article-title><source>Front. Bioeng. Biotechnol.</source><volume>8</volume><year>2020</year><fpage>586406</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2020.586406</pub-id><pub-id pub-id-type="pmid">33251199</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Corona-Gomez</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name></person-group><article-title>Effect of nanoparticle incorporation and surface coating on mechanical properties of bone scaffolds: a brief review</article-title><source>J.&#x000a0;Funct. Biomater.</source><volume>7</volume><year>2016</year><pub-id pub-id-type="doi">10.3390/jfb7030018</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Damour</surname><given-names>O.</given-names></name><name><surname>Hua</surname><given-names>S.Z.</given-names></name><name><surname>Lasne</surname><given-names>F.</given-names></name><name><surname>Villain</surname><given-names>M.</given-names></name><name><surname>Rousselle</surname><given-names>P.</given-names></name><name><surname>Collombel</surname><given-names>C.</given-names></name></person-group><article-title>Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes</article-title><source>Burns</source><volume>18</volume><year>1992</year><fpage>479</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/0305-4179(92)90180-3</pub-id><pub-id pub-id-type="pmid">1489497</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Darouiche</surname><given-names>R.O.</given-names></name></person-group><article-title>Treatment of infections associated with surgical implants</article-title><source>N.&#x000a0;Engl. J. Med.</source><volume>350</volume><year>2004</year><fpage>1422</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1056/NEJMra035415</pub-id><pub-id pub-id-type="pmid">15070792</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>K.P.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Bellinger-Kawahara</surname><given-names>C.</given-names></name><name><surname>Joh</surname><given-names>D.</given-names></name><name><surname>Hawkinson</surname><given-names>M.J.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name><name><surname>Purchio</surname><given-names>T.F.</given-names></name><name><surname>Caparon</surname><given-names>M.G.</given-names></name><name><surname>Lipsitch</surname><given-names>M.</given-names></name><name><surname>Contag</surname><given-names>P.R.</given-names></name></person-group><article-title>Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon</article-title><source>Infect. Immun.</source><volume>69</volume><year>2001</year><fpage>3350</fpage><lpage>3358</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.5.3350-3358.2001</pub-id><pub-id pub-id-type="pmid">11292758</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>C.</given-names></name><name><surname>Evans</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Vargas</surname><given-names>M.</given-names></name><name><surname>Kabboul</surname><given-names>G.</given-names></name><name><surname>Fulton</surname><given-names>T.</given-names></name><name><surname>Veneziano</surname><given-names>R.</given-names></name><name><surname>Nick</surname><given-names>N.</given-names></name><name><surname>Bauser-Heaton</surname><given-names>H.</given-names></name><name><surname>Roeder</surname><given-names>R.K.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><article-title>Abstract MP207: a precision medicine approach for non-invasive, longitudinal, and quantitative monitoring of cardiac tissue-engineered scaffolds</article-title><source>Circ. Res.</source><volume>129</volume><year>2021</year><fpage>AMP207</fpage><pub-id pub-id-type="doi">10.1161/res.129.suppl_1.MP207</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>R.</given-names></name><name><surname>Dempsey-Hibbert</surname><given-names>N.C.</given-names></name><name><surname>Whitehead</surname><given-names>K.A.</given-names></name></person-group><article-title>Antimicrobial strategies to reduce polymer biomaterial infections and their economic implications and considerations</article-title><source>Int. Biodeterior. Biodegrad.</source><volume>136</volume><year>2019</year><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.ibiod.2018.10.005</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Gristina</surname><given-names>A.G.</given-names></name></person-group><article-title>Biomaterial-centered infection: microbial adhesion versus tissue integration</article-title><source>Science</source><volume>237</volume><year>1987</year><fpage>1588</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1126/science.3629258</pub-id><pub-id pub-id-type="pmid">3629258</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Hajipour</surname><given-names>M.J.</given-names></name><name><surname>Fromm</surname><given-names>K.M.</given-names></name><name><surname>Akbar Ashkarran</surname><given-names>A.</given-names></name><name><surname>Jimenez de Aberasturi</surname><given-names>D.</given-names></name><name><surname>Larramendi</surname><given-names>I.R.d.</given-names></name><name><surname>Rojo</surname><given-names>T.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Parak</surname><given-names>W.J.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Antibacterial properties of nanoparticles</article-title><source>Trends Biotechnol.</source><volume>30</volume><year>2012</year><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2012.06.004</pub-id><pub-id pub-id-type="pmid">22884769</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Hajipour</surname><given-names>M.J.</given-names></name><name><surname>Saei</surname><given-names>A.A.</given-names></name><name><surname>Walker</surname><given-names>E.D.</given-names></name><name><surname>Conley</surname><given-names>B.</given-names></name><name><surname>Omidi</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>K.B.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Nanotechnology for targeted detection and removal of bacteria: opportunities and challenges</article-title><source>Adv. Sci.</source><volume>8</volume><year>2021</year><fpage>e2100556</fpage><pub-id pub-id-type="doi">10.1002/advs.202100556</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>A.</given-names></name><name><surname>Morshed</surname><given-names>M.</given-names></name><name><surname>Memic</surname><given-names>A.</given-names></name><name><surname>Hassan</surname><given-names>S.</given-names></name><name><surname>Webster</surname><given-names>T.J.</given-names></name><name><surname>Marei</surname><given-names>H.E.</given-names></name></person-group><article-title>Nanoparticles in tissue engineering: applications, challenges and prospects</article-title><source>Int. J. Nanomed.</source><volume>13</volume><year>2018</year><fpage>5637</fpage><lpage>5655</lpage><pub-id pub-id-type="doi">10.2147/IJN.S153758</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>H&#x000f6;lzl</surname><given-names>K.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Tytgat</surname><given-names>L.</given-names></name><name><surname>Van Vlierberghe</surname><given-names>S.</given-names></name><name><surname>Gu</surname><given-names>L.</given-names></name><name><surname>Ovsianikov</surname><given-names>A.</given-names></name></person-group><article-title>Bioink properties before, during and after 3D bioprinting</article-title><source>Biofabrication</source><volume>8</volume><year>2016</year><fpage>032002</fpage><pub-id pub-id-type="doi">10.1088/1758-5090/8/3/032002</pub-id><pub-id pub-id-type="pmid">27658612</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>T.J.</given-names></name></person-group><article-title>Engineering three-dimensional cell mechanical microenvironment with hydrogels</article-title><source>Biofabrication</source><volume>4</volume><year>2012</year><fpage>042001</fpage><pub-id pub-id-type="doi">10.1088/1758-5082/4/4/042001</pub-id><pub-id pub-id-type="pmid">23164720</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>C.T.</given-names></name><name><surname>Garcia</surname><given-names>A.J.</given-names></name></person-group><article-title>Scaffold-based anti-infection strategies in bone repair</article-title><source>Ann. Biomed. Eng.</source><volume>43</volume><year>2015</year><fpage>515</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1007/s10439-014-1205-3</pub-id><pub-id pub-id-type="pmid">25476163</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Khezerlou</surname><given-names>A.</given-names></name><name><surname>Alizadeh-Sani</surname><given-names>M.</given-names></name><name><surname>Azizi-Lalabadi</surname><given-names>M.</given-names></name><name><surname>Ehsani</surname><given-names>A.</given-names></name></person-group><article-title>Nanoparticles and their antimicrobial properties against pathogens including bacteria, fungi, parasites and viruses</article-title><source>Microb. Pathog.</source><volume>123</volume><year>2018</year><fpage>505</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.08.008</pub-id><pub-id pub-id-type="pmid">30092260</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>B.</given-names></name><name><surname>Seog</surname><given-names>J.H.</given-names></name><name><surname>Graham</surname><given-names>L.M.</given-names></name><name><surname>Lee</surname><given-names>S.B.</given-names></name></person-group><article-title>Experimental considerations on the cytotoxicity of nanoparticles</article-title><source>Nanomedicine (London, England)</source><volume>6</volume><year>2011</year><fpage>929</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.2217/nnm.11.77</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Kuijer</surname><given-names>R.</given-names></name><name><surname>Jansen</surname><given-names>E.J.</given-names></name><name><surname>Emans</surname><given-names>P.J.</given-names></name><name><surname>Bulstra</surname><given-names>S.K.</given-names></name><name><surname>Riesle</surname><given-names>J.</given-names></name><name><surname>Pieper</surname><given-names>J.</given-names></name><name><surname>Grainger</surname><given-names>D.W.</given-names></name><name><surname>Busscher</surname><given-names>H.J.</given-names></name></person-group><article-title>Assessing infection risk in implanted tissue-engineered devices</article-title><source>Biomaterials</source><volume>28</volume><year>2007</year><fpage>5148</fpage><lpage>5154</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.06.003</pub-id><pub-id pub-id-type="pmid">17597202</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.S.D.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Advancement of nanobiomaterials to deliver natural compounds for tissue engineering applications</article-title><source>Int. J. Mol. Sci.</source><volume>21</volume><year>2020</year><pub-id pub-id-type="doi">10.3390/ijms21186752</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Kurian</surname><given-names>A.G.</given-names></name><name><surname>Singh</surname><given-names>R.K.</given-names></name><name><surname>Patel</surname><given-names>K.D.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.W.</given-names></name></person-group><article-title>Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics</article-title><source>Bioact. Mater.</source><volume>8</volume><year>2022</year><fpage>267</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2021.06.027</pub-id><pub-id pub-id-type="pmid">34541401</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>H.-W.</given-names></name></person-group><article-title>Emerging properties of hydrogels in tissue engineering</article-title><source>J.&#x000a0;Tissue Eng.</source><volume>9</volume><year>2018</year><pub-id pub-id-type="doi">10.1177/2041731418768285</pub-id><comment>2041731418768285</comment></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Gil</surname><given-names>C.J.</given-names></name><name><surname>Finamore</surname><given-names>T.A.</given-names></name><name><surname>Evans</surname><given-names>C.J.</given-names></name><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Theus</surname><given-names>A.</given-names></name><name><surname>Kabboul</surname><given-names>G.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Roeder</surname><given-names>R.K.</given-names></name></person-group><article-title>Methacrylate-modified gold nanoparticles enable non-invasive monitoring of photocrosslinked hydrogel scaffolds</article-title><comment>Preprint at</comment><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.01.26.477960</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Luo</surname><given-names>K.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Lan</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name></person-group><article-title>Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking</article-title><source>Theranostics</source><volume>3</volume><year>2013</year><fpage>595</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.7150/thno.5366</pub-id><pub-id pub-id-type="pmid">23946825</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Magnuson</surname><given-names>M.</given-names></name><name><surname>Majeed</surname><given-names>W.</given-names></name><name><surname>Keilholz</surname><given-names>S.D.</given-names></name></person-group><article-title>Functional connectivity in blood oxygenation level-dependent and cerebral blood volume-weighted resting state functional magnetic resonance imaging in the rat brain</article-title><source>J.&#x000a0;Magn. Reson. Imag.</source><volume>32</volume><year>2010</year><fpage>584</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1002/jmri.22295</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Hofmann</surname><given-names>H.</given-names></name><name><surname>Rothen-Rutishauser</surname><given-names>B.</given-names></name><name><surname>Petri-Fink</surname><given-names>A.</given-names></name></person-group><article-title>Assessing the in&#x000a0;vitro and in&#x000a0;vivo toxicity of superparamagnetic iron oxide nanoparticles</article-title><source>Chem. Rev.</source><volume>112</volume><year>2012</year><fpage>2323</fpage><lpage>2338</lpage><pub-id pub-id-type="doi">10.1021/cr2002596</pub-id><pub-id pub-id-type="pmid">22216932</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Saeedi-Eslami</surname><given-names>S.N.</given-names></name><name><surname>Shokrgozar</surname><given-names>M.A.</given-names></name><name><surname>Azadmanesh</surname><given-names>K.</given-names></name><name><surname>Hassanlou</surname><given-names>M.</given-names></name><name><surname>Kalhor</surname><given-names>H.R.</given-names></name><name><surname>Burtea</surname><given-names>C.</given-names></name><name><surname>Rothen-Rutishauser</surname><given-names>B.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>Sheibani</surname><given-names>S.</given-names></name><name><surname>Vali</surname><given-names>H.</given-names></name></person-group><article-title>Cell "vision": complementary factor of protein corona in nanotoxicology</article-title><source>Nanoscale</source><volume>4</volume><year>2012</year><fpage>5461</fpage><lpage>5468</lpage><pub-id pub-id-type="doi">10.1039/c2nr31185b</pub-id><pub-id pub-id-type="pmid">22842341</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Sant</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>Sen</surname><given-names>T.</given-names></name></person-group><article-title>Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy</article-title><source>Adv. Drug Deliv. Rev.</source><volume>63</volume><year>2011</year><fpage>24</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2010.05.006</pub-id><pub-id pub-id-type="pmid">20685224</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><article-title>Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat</article-title><source>ACS Nano</source><volume>6</volume><year>2012</year><fpage>2656</fpage><lpage>2664</lpage><pub-id pub-id-type="doi">10.1021/nn300042m</pub-id><pub-id pub-id-type="pmid">22397679</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name></person-group><article-title>Engineered nanoparticles for biomolecular imaging</article-title><source>Nanoscale</source><volume>3</volume><year>2011</year><fpage>3007</fpage><lpage>3026</lpage><pub-id pub-id-type="doi">10.1039/c1nr10326a</pub-id><pub-id pub-id-type="pmid">21717012</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Matsuura</surname><given-names>Y.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>P.C.</given-names></name><name><surname>Bernstein</surname><given-names>D.</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><article-title>Infection-resistant MRI-visible scaffolds for tissue engineering applications</article-title><source>Bioimpacts</source><volume>6</volume><year>2016</year><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.15171/bi.2016.16</pub-id><pub-id pub-id-type="pmid">27525229</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>G.J.</given-names></name><name><surname>Morgan</surname><given-names>E.F.</given-names></name></person-group><article-title>Use of microindentation to characterize the mechanical properties of articular cartilage: comparison of biphasic material properties across length scales</article-title><source>Osteoarthritis Cartilage</source><volume>18</volume><year>2010</year><fpage>1051</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2010.04.007</pub-id><pub-id pub-id-type="pmid">20417292</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="book" id="sref42"><person-group person-group-type="author"><name><surname>ML Tomov</surname><given-names>A.T.</given-names></name><name><surname>Cetnar</surname><given-names>A.</given-names></name><name><surname>Bauser-Heaton</surname><given-names>H.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><part-title>Vascularized Multi-Tissue Platform &#x02013; 3D Bioprinting an Organ Model in&#x000a0;Vitro</part-title><year>2019</year></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>M.A.</given-names></name><name><surname>Nasr</surname><given-names>M.</given-names></name><name><surname>Elkhatib</surname><given-names>W.F.</given-names></name><name><surname>Eltayeb</surname><given-names>W.N.</given-names></name></person-group><article-title>In&#x000a0;vitro evaluation of antimicrobial activity and cytotoxicity of different nanobiotics targeting multidrug resistant and biofilm forming staphylococci</article-title><source>BioMed Res. Int.</source><year>2018</year><fpage>7658238</fpage><pub-id pub-id-type="doi">10.1155/2018/7658238</pub-id><pub-id pub-id-type="pmid">30622962</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Naderi</surname><given-names>H.</given-names></name><name><surname>Matin</surname><given-names>M.M.</given-names></name><name><surname>Bahrami</surname><given-names>A.R.</given-names></name></person-group><article-title>Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems</article-title><source>J.&#x000a0;Biomater. Appl.</source><volume>26</volume><year>2011</year><fpage>383</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1177/0885328211408946</pub-id><pub-id pub-id-type="pmid">21926148</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Nehra</surname><given-names>P.</given-names></name><name><surname>Chauhan</surname><given-names>R.P.</given-names></name><name><surname>Garg</surname><given-names>N.</given-names></name><name><surname>Verma</surname><given-names>K.</given-names></name></person-group><article-title>Antibacterial and antifungal activity of chitosan coated iron oxide nanoparticles</article-title><source>Br. J. Biomed. Sci.</source><volume>75</volume><year>2018</year><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1080/09674845.2017.1347362</pub-id><pub-id pub-id-type="pmid">28945174</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Neuwelt</surname><given-names>A.</given-names></name><name><surname>Sidhu</surname><given-names>N.</given-names></name><name><surname>Hu</surname><given-names>C.A.</given-names></name><name><surname>Mlady</surname><given-names>G.</given-names></name><name><surname>Eberhardt</surname><given-names>S.C.</given-names></name><name><surname>Sillerud</surname><given-names>L.O.</given-names></name></person-group><article-title>Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation</article-title><source>AJR Am. J. Roentgenol.</source><volume>204</volume><year>2015</year><fpage>W302</fpage><lpage>W313</lpage><pub-id pub-id-type="doi">10.2214/AJR.14.12733</pub-id><pub-id pub-id-type="pmid">25714316</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Mehta</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Theus</surname><given-names>A.</given-names></name><name><surname>Tomov</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Weeks</surname><given-names>E.R.</given-names></name><name><surname>Bauser-Heaton</surname><given-names>H.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><article-title>Embedded 3D bioprinting of gelatin methacryloyl-based constructs with highly tunable structural fidelity</article-title><source>ACS Appl. Mater. Interfaces</source><volume>12</volume><year>2020</year><fpage>44563</fpage><lpage>44577</lpage><pub-id pub-id-type="doi">10.1021/acsami.0c15078</pub-id><pub-id pub-id-type="pmid">32966746</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Shim</surname><given-names>J.</given-names></name><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Mehta</surname><given-names>R.</given-names></name><name><surname>Mingee</surname><given-names>A.</given-names></name><name><surname>Hwang</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Mantalaris</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A 3D bioprinted in&#x000a0;vitro model of neuroblastoma recapitulates dynamic tumor-endothelial cell interactions contributing to solid tumor Aggressive behavior</article-title><source>Adv. Sci.</source><year>2022</year><fpage>e2200244</fpage><pub-id pub-id-type="doi">10.1002/advs.202200244</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Rajaram</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Srinivasan</surname><given-names>S.</given-names></name><name><surname>Mohabatpour</surname><given-names>F.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>McLnnes</surname><given-names>A.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Noninvasive three-dimensional in&#x000a0;situ and in&#x000a0;vivo characterization of bioprinted hydrogel scaffolds using the X-ray propagation-based imaging technique</article-title><source>ACS Appl. Mater. Interfaces</source><volume>13</volume><year>2021</year><fpage>25611</fpage><lpage>25623</lpage><pub-id pub-id-type="doi">10.1021/acsami.1c02297</pub-id><pub-id pub-id-type="pmid">34038086</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>I.</given-names></name><name><surname>Orton</surname><given-names>T.</given-names></name><name><surname>Pognan</surname><given-names>F.</given-names></name></person-group><article-title>Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity</article-title><source>Eur. J. Biochem.</source><volume>267</volume><year>2000</year><fpage>5421</fpage><lpage>5426</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01606.x</pub-id><pub-id pub-id-type="pmid">10951200</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Offerhaus</surname><given-names>C.</given-names></name><name><surname>Balke</surname><given-names>M.</given-names></name><name><surname>Hente</surname><given-names>J.</given-names></name><name><surname>Gehling</surname><given-names>M.</given-names></name><name><surname>Blendl</surname><given-names>S.</given-names></name><name><surname>H&#x000f6;her</surname><given-names>J.</given-names></name></person-group><article-title>Vancomycin pre-soaking of the graft reduces postoperative infection rate without increasing risk of graft failure and arthrofibrosis in ACL reconstruction</article-title><source>Knee Surg. Sports Traumatol. Arthrosc.</source><volume>27</volume><year>2019</year><fpage>3014</fpage><lpage>3021</lpage><pub-id pub-id-type="doi">10.1007/s00167-018-5323-6</pub-id><pub-id pub-id-type="pmid">30666370</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>W.C.</given-names></name><name><surname>Pharr</surname><given-names>G.M.</given-names></name></person-group><article-title>An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments</article-title><source>J.&#x000a0;Mater. Res.</source><volume>7</volume><year>1992</year><fpage>1564</fpage><lpage>1583</lpage></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>W.C.</given-names></name><name><surname>Pharr</surname><given-names>G.M.</given-names></name></person-group><article-title>Measurement of hardness and elastic modulus by instrumented indentation: advances in understanding and refinements to methodology</article-title><source>J.&#x000a0;Mater. Res.</source><volume>19</volume><year>2004</year><fpage>3</fpage><lpage>20</lpage></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Pottler</surname><given-names>M.</given-names></name><name><surname>Fliedner</surname><given-names>A.</given-names></name><name><surname>Schreiber</surname><given-names>E.</given-names></name><name><surname>Janko</surname><given-names>C.</given-names></name><name><surname>Friedrich</surname><given-names>R.P.</given-names></name><name><surname>Bohr</surname><given-names>C.</given-names></name><name><surname>Dollinger</surname><given-names>M.</given-names></name><name><surname>Alexiou</surname><given-names>C.</given-names></name><name><surname>Durr</surname><given-names>S.</given-names></name></person-group><article-title>Impact of superparamagnetic iron oxide nanoparticles on vocal fold fibroblasts: cell behavior and cellular iron kinetics</article-title><source>Nanoscale Res. Lett.</source><volume>12</volume><year>2017</year><fpage>284</fpage><pub-id pub-id-type="doi">10.1186/s11671-017-2045-5</pub-id><pub-id pub-id-type="pmid">28431461</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>An</surname><given-names>Y.H.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name></person-group><article-title>Biomaterial strategies to reduce implant-associated infections</article-title><source>Int. J. Artif. Organs</source><volume>30</volume><year>2007</year><fpage>828</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1177/039139880703000913</pub-id><pub-id pub-id-type="pmid">17918129</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Rejman</surname><given-names>J.</given-names></name><name><surname>Oberle</surname><given-names>V.</given-names></name><name><surname>Zuhorn</surname><given-names>I.S.</given-names></name><name><surname>Hoekstra</surname><given-names>D.</given-names></name></person-group><article-title>Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis</article-title><source>Biochem. J.</source><volume>377</volume><year>2004</year><fpage>159</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1042/BJ20031253</pub-id><pub-id pub-id-type="pmid">14505488</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Saei</surname><given-names>A.A.</given-names></name><name><surname>Yazdani</surname><given-names>M.</given-names></name><name><surname>Lohse</surname><given-names>S.E.</given-names></name><name><surname>Bakhtiary</surname><given-names>Z.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Ghavami</surname><given-names>M.</given-names></name><name><surname>Asadian</surname><given-names>M.</given-names></name><name><surname>Mashaghi</surname><given-names>S.</given-names></name><name><surname>Dreaden</surname><given-names>E.C.</given-names></name><name><surname>Mashaghi</surname><given-names>A.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Nanoparticle surface functionality dictates cellular and systemic toxicity</article-title><source>Chem. Mater.</source><volume>29</volume><year>2017</year><fpage>6578</fpage><lpage>6595</lpage><pub-id pub-id-type="doi">10.1021/acs.chemmater.7b01979</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>D.</given-names></name><name><surname>Kannan</surname><given-names>G.M.</given-names></name><name><surname>Tailang</surname><given-names>M.</given-names></name><name><surname>Vijayaraghavan</surname><given-names>R.</given-names></name></person-group><article-title>In&#x000a0;vitro cytotoxicity of nanoparticles: a comparison between particle size and cell type</article-title><source>J.&#x000a0;Nanosci.</source><year>2016</year><fpage>4023852</fpage><pub-id pub-id-type="doi">10.1155/2016/4023852</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Salingova</surname><given-names>B.</given-names></name><name><surname>Simara</surname><given-names>P.</given-names></name><name><surname>Matula</surname><given-names>P.</given-names></name><name><surname>Zajickova</surname><given-names>L.</given-names></name><name><surname>Synek</surname><given-names>P.</given-names></name><name><surname>Jasek</surname><given-names>O.</given-names></name><name><surname>Veverkova</surname><given-names>L.</given-names></name><name><surname>Sedlackova</surname><given-names>M.</given-names></name><name><surname>Nichtova</surname><given-names>Z.</given-names></name><name><surname>Koutna</surname><given-names>I.</given-names></name></person-group><article-title>The effect of uncoated SPIONs on hiPSC-differentiated endothelial cells</article-title><source>Int. J. Mol. Sci.</source><volume>20</volume><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20143536</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="book" id="sref60"><person-group person-group-type="author"><name><surname>Scientific</surname><given-names>W.</given-names></name></person-group><part-title>Cell sources for bioprinting</part-title><source>Bioprinting</source><year>2015</year><fpage>165</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1142/9789814612128_0005</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Guvendiren</surname><given-names>M.</given-names></name></person-group><article-title>Editorial for the special issue on 3D printing for tissue engineering and regenerative medicine</article-title><source>Micromachines</source><volume>11</volume><year>2020</year><pub-id pub-id-type="doi">10.3390/mi11040366</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Sheibani</surname><given-names>S.</given-names></name><name><surname>Pushparaj</surname><given-names>P.</given-names></name><name><surname>Wojcik</surname><given-names>M.</given-names></name><name><surname>Jang</surname><given-names>A.Y.</given-names></name><name><surname>Santoso</surname><given-names>M.R.</given-names></name><name><surname>Jang</surname><given-names>J.H.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Safavi-Sohi</surname><given-names>R.</given-names></name><name><surname>Haghjoo</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Effect of cell sex on uptake of nanoparticles: the overlooked factor at the nanobio interface</article-title><source>ACS Nano</source><volume>12</volume><year>2018</year><fpage>2253</fpage><lpage>2266</lpage><pub-id pub-id-type="doi">10.1021/acsnano.7b06212</pub-id><pub-id pub-id-type="pmid">29536733</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Metzler</surname><given-names>S.A.</given-names></name><name><surname>Wei</surname><given-names>K.</given-names></name><name><surname>Shah</surname><given-names>P.B.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Malkovskiy</surname><given-names>A.V.</given-names></name><name><surname>Rajadas</surname><given-names>J.</given-names></name><name><surname>Butte</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction</article-title><source>Biomaterials</source><volume>34</volume><year>2013</year><fpage>9048</fpage><lpage>9055</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.08.017</pub-id><pub-id pub-id-type="pmid">23992980</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>S.</given-names></name><name><surname>Behzadi</surname><given-names>S.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>Forrest</surname><given-names>M.L.</given-names></name><name><surname>Stroeve</surname><given-names>P.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Toxicity of nanomaterials</article-title><source>Chem. Soc. Rev.</source><volume>41</volume><year>2012</year><fpage>2323</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1039/c1cs15188f</pub-id><pub-id pub-id-type="pmid">22170510</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Shirahama</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>B.H.</given-names></name><name><surname>Tan</surname><given-names>L.P.</given-names></name><name><surname>Cho</surname><given-names>N.-J.</given-names></name></person-group><article-title>Precise tuning of facile one-pot gelatin methacryloyl (GelMA) synthesis</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><fpage>31036</fpage><pub-id pub-id-type="doi">10.1038/srep31036</pub-id><pub-id pub-id-type="pmid">27503340</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Shokouhimehr</surname><given-names>M.</given-names></name><name><surname>Theus</surname><given-names>A.S.</given-names></name><name><surname>Kamalakar</surname><given-names>A.</given-names></name><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Kaiser</surname><given-names>J.M.</given-names></name><name><surname>Goudy</surname><given-names>S.</given-names></name><name><surname>Willett</surname><given-names>N.J.</given-names></name><name><surname>Jang</surname><given-names>H.W.</given-names></name><etal/></person-group><article-title>3D bioprinted bacteriostatic hyperelastic bone scaffold for damage-specific bone regeneration</article-title><source>Polymers</source><volume>13</volume><year>2021</year><pub-id pub-id-type="doi">10.3390/polym13071099</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Siebert</surname><given-names>L.</given-names></name><name><surname>Luna-Cer&#x000f3;n</surname><given-names>E.</given-names></name><name><surname>Garc&#x000ed;a-Rivera</surname><given-names>L.E.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Jang</surname><given-names>J.</given-names></name><name><surname>Rosas-G&#x000f3;mez</surname><given-names>D.A.</given-names></name><name><surname>P&#x000e9;rez-G&#x000f3;mez</surname><given-names>M.D.</given-names></name><name><surname>Maschkowitz</surname><given-names>G.</given-names></name><name><surname>Fickenscher</surname><given-names>H.</given-names></name><name><surname>Oceguera-Cuevas</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Light-controlled growth factors release on tetrapodal ZnO-incorporated 3D-printed hydrogels for developing smart wound scaffold</article-title><source>Adv. Funct. Mater.</source><volume>31</volume><year>2021</year><fpage>2007555</fpage><pub-id pub-id-type="doi">10.1002/adfm.202007555</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Choudhury</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Mironov</surname><given-names>V.</given-names></name><name><surname>Naing</surname><given-names>M.W.</given-names></name></person-group><article-title>In situ bioprinting - bioprinting from benchside to bedside?</article-title><source>Acta Biomater.</source><volume>101</volume><year>2020</year><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2019.08.045</pub-id><pub-id pub-id-type="pmid">31476384</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Speert</surname><given-names>D.P.</given-names></name></person-group><article-title>Antimicrobial resistance: implications for therapy of infections with common childhood pathogens</article-title><source>Can. J. Infect Dis.</source><volume>7</volume><year>1996</year><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1155/1996/431214</pub-id><pub-id pub-id-type="pmid">22514433</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>E.N.</given-names></name><name><surname>Kummer</surname><given-names>K.M.</given-names></name><name><surname>Durmus</surname><given-names>N.G.</given-names></name><name><surname>Leuba</surname><given-names>K.</given-names></name><name><surname>Tarquinio</surname><given-names>K.M.</given-names></name><name><surname>Webster</surname><given-names>T.J.</given-names></name></person-group><article-title>Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms</article-title><source>Small</source><volume>8</volume><year>2012</year><fpage>3016</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1002/smll.201200575</pub-id><pub-id pub-id-type="pmid">22777831</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Gil</surname><given-names>C.J.</given-names></name><name><surname>Cetnar</surname><given-names>A.</given-names></name><name><surname>Theus</surname><given-names>A.S.</given-names></name><name><surname>Lima</surname><given-names>B.J.</given-names></name><name><surname>Nish</surname><given-names>J.E.</given-names></name><name><surname>Bauser-Heaton</surname><given-names>H.D.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><article-title>Engineering functional cardiac tissues for regenerative medicine applications</article-title><source>Curr. Cardiol. Rep.</source><volume>21</volume><year>2019</year><fpage>105</fpage><pub-id pub-id-type="doi">10.1007/s11886-019-1178-9</pub-id><pub-id pub-id-type="pmid">31367922</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="book" id="sref72"><person-group person-group-type="author"><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Theus</surname><given-names>A.</given-names></name><name><surname>Sarasani</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><part-title>3D bioprinting of cardiovascular tissue constructs: cardiac bioinks</part-title><person-group person-group-type="editor"><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Wu</surname><given-names>S.M.</given-names></name></person-group><source>Cardiovascular Regenerative Medicine: Tissue Engineering and Clinical Applications</source><year>2019</year><publisher-name>Springer International Publishing</publisher-name><fpage>63</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-20047-3_4</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="book" id="sref73"><person-group person-group-type="author"><name><surname>Tomov</surname><given-names>M.L.</given-names></name><name><surname>Vargas</surname><given-names>M.</given-names></name><name><surname>Gil</surname><given-names>C.J.</given-names></name><name><surname>Theus</surname><given-names>A.S.</given-names></name><name><surname>Cetnar</surname><given-names>A.C.</given-names></name><name><surname>Pham Do</surname><given-names>K.</given-names></name><name><surname>Veneziano</surname><given-names>R.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name></person-group><part-title>Chapter 12 - nano-bioink solutions for cardiac tissue bioprinting</part-title><person-group person-group-type="editor"><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><source>Nanomedicine for Ischemic Cardiomyopathy</source><year>2020</year><publisher-name>Academic Press</publisher-name><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-817434-0.00012-X</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>N.</given-names></name><name><surname>Mir</surname><given-names>A.</given-names></name><name><surname>Mallik</surname><given-names>D.</given-names></name><name><surname>Sinha</surname><given-names>A.</given-names></name><name><surname>Nayar</surname><given-names>S.</given-names></name><name><surname>Webster</surname><given-names>T.J.</given-names></name></person-group><article-title>Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus</article-title><source>Int. J. Nanomed.</source><volume>5</volume><year>2010</year><fpage>277</fpage></element-citation></ref><ref id="bib75"><element-citation publication-type="book" id="sref75"><person-group person-group-type="author"><name><surname>Uskokovic</surname><given-names>V.</given-names></name></person-group><part-title>Nanotechnologies in Preventive and Regenerative Medicine: An Emerging Big Picture</part-title><year>2017</year><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Vigata</surname><given-names>M.</given-names></name><name><surname>O'Connell</surname><given-names>C.D.</given-names></name><name><surname>Cometta</surname><given-names>S.</given-names></name><name><surname>Hutmacher</surname><given-names>D.W.</given-names></name><name><surname>Meinert</surname><given-names>C.</given-names></name><name><surname>Bock</surname><given-names>N.</given-names></name></person-group><article-title>Gelatin methacryloyl hydrogels for the localized delivery of cefazolin</article-title><source>Polymers</source><volume>13</volume><year>2021</year><pub-id pub-id-type="doi">10.3390/polym13223960</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name></person-group><article-title>The antimicrobial activity of nanoparticles: present situation and prospects for the future</article-title><source>Int. J. Nanomed.</source><volume>12</volume><year>2017</year><fpage>1227</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.2147/IJN.S121956</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Qian</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name></person-group><article-title>Superparamagnetic iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications</article-title><source>Int. J. Nanomed.</source><volume>16</volume><year>2021</year><fpage>6097</fpage><lpage>6113</lpage><pub-id pub-id-type="doi">10.2147/IJN.S321984</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>K.</given-names></name><name><surname>Serpooshan</surname><given-names>V.</given-names></name><name><surname>Hurtado</surname><given-names>C.</given-names></name><name><surname>Diez-Cunado</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Maruyama</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Fajardo</surname><given-names>G.</given-names></name><name><surname>Noseda</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Epicardial FSTL1 reconstitution regenerates the adult mammalian heart</article-title><source>Nature</source><volume>525</volume><year>2015</year><fpage>479</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/nature15372</pub-id><pub-id pub-id-type="pmid">26375005</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="book" id="sref80"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>K.</given-names></name><name><surname>Trujillo-de Santiago</surname><given-names>G.</given-names></name><name><surname>Alvarez</surname><given-names>M.M.</given-names></name><name><surname>Tamayol</surname><given-names>A.</given-names></name><name><surname>Annabi</surname><given-names>N.</given-names></name><name><surname>Khademhosseini</surname><given-names>A.</given-names></name></person-group><part-title>Synthesis, Properties, and Biomedical Applications of Gelatin Methacryloyl (GelMA) Hydrogels</part-title><year>2015</year><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib81"><element-citation publication-type="book" id="sref81"><person-group person-group-type="author"><name><surname>Zimmerli</surname><given-names>W.</given-names></name><name><surname>Trampuz</surname><given-names>A.</given-names></name></person-group><part-title>Biomaterial-associated infection: a perspective from the clinic</part-title><person-group person-group-type="editor"><name><surname>Moriarty</surname><given-names>T.F.</given-names></name><name><surname>Zaat</surname><given-names>S.A.J.</given-names></name><name><surname>Busscher</surname><given-names>H.J.</given-names></name></person-group><source>Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies</source><year>2013</year><publisher-name>Springer New York</publisher-name><fpage>3</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1007/978-1-4614-1031-7_1</pub-id></element-citation></ref></ref-list><sec id="appsec2" sec-type="supplementary-material"><title>Supplemental information</title><p id="p0235">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figure&#x000a0;S1 and Tables&#x000a0;S1 and S2</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p></sec><sec sec-type="data-availability" id="da0010"><title>Data and code availability</title><p id="p0025">
<list list-type="simple" id="ulist0015"><list-item id="u0025"><label>&#x02022;</label><p id="p0030">All data reported in this work will be shared by the <xref rid="sec3.2.1" ref-type="sec">lead contact</xref> upon reasonable request.</p></list-item><list-item id="u0030"><label>&#x02022;</label><p id="p0035">This work has no original code and custom computer code.</p></list-item><list-item id="u0035"><label>&#x02022;</label><p id="p0040">Any additional information required to reanalyze the data reported in this work is available from the <xref rid="sec3.2.1" ref-type="sec">Lead contact</xref> upon request.</p></list-item></list>
</p></sec><ack id="ack0010"><title>Acknowledgment</title><p id="p0215">The authors acknowledge the support from the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> (R00 HL127295 and R01 MH126195 to V.S., and <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000060</institution-id><institution>NIAID</institution></institution-wrap></funding-source> R01 AI153071 to C.L.), <funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source> (NSF CAREER Award to V.S.), and <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100006939</institution-id><institution>Emory University</institution></institution-wrap></funding-source> Dean&#x02019;s Imagine, Innovate and Impact (I3) Research Award (to V.S.). Research reported in this publication was supported in part by the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/100006939</institution-id><institution>Emory University</institution></institution-wrap></funding-source> Integrated Cellular Imaging (ICI) Core and Children&#x02019;s Healthcare of Atlanta (<funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/100012423</institution-id><institution>CHOA</institution></institution-wrap></funding-source>). M.M. gratefully acknowledges financial support from the <funding-source id="gs7">U.S. National Institute of Diabetes and Digestive and Kidney Diseases</funding-source> (grant DK131417).</p><sec id="sec4"><title>Author contributions</title><p id="p0220">Conceptualization, V.S.; Funding, V.S., C.L., M.M.; Original Draft, A.T., L.N., V.S.; Experiments: A.T., L.N., G.K.; Data Curation and Analysis, A.T., G.K., B.H., M.T., C.L.; Revision, V.S., H.B.H.; Resources, C.L., H.B.H., M.M., V.S.</p></sec><sec sec-type="COI-statement" id="sec5"><title>Declaration of interests</title><p id="p0225">Author V.S. is a Guest Editor on the <italic>Advanced Manufacturing of Tissue Constructs</italic> Special Issue published in iScience. Author M.M. discloses that (i)&#x000a0;he is a co-founder and director of the Academic Parity Movement (<ext-link ext-link-type="uri" xlink:href="http://www.paritymovement.org" id="intref0015">www.paritymovement.org</ext-link>), a non-profit organization dedicated to addressing academic discrimination, violence and incivility; (ii) he is a Founding Partner at Partners in Global Wound Care (PGWC); and (iii) he receives royalties/honoraria for his published books, plenary lectures, and licensed patents.</p></sec></ack><fn-group><fn id="appsec1" fn-type="supplementary-material"><p id="p0230">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2022.104947" id="intref0020">https://doi.org/10.1016/j.isci.2022.104947</ext-link>.</p></fn></fn-group></back></article>
